MIRA INFORM REPORT

 

 

Report Date :           

08.02.2012

 

IDENTIFICATION DETAILS

 

Name :

ERCROS SA

 

 

Registered Office :

Av. Diagonal, 595, Barcelona, 08014

 

 

Country :

Spain

 

 

Financials (as on) :

31.12.2010

 

 

Date of Incorporation :

30.06.1989

 

 

Legal Form :

Public Parent Company

 

 

Line of Business :

Subject is engaged in the chemical industry

 

 

No. of Employees :

1629

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

----

 


NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30th, 2011

 

Country Name

Previous Rating

                   (30.06.2011)                  

Current Rating

(30.09.2011)

Spain

a2

a2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


Company name & address 

 

Ercros SA

Av. Diagonal, 595

Barcelona, 08014

Spain

Tel:       34-934-393009

Fax:      34-934-308073

Web:    www.ercros.es

 

 

synthesis  

 

Employees:                  1629

Corporate Family:          3 Companies

Traded:                         Mercado Continuo Espana:         ECR

Incorporation Date:         30-Jun-1989

Auditor:                        Ernst & Young SA        

Financials in:                 USD (Millions)

Fiscal Year End:            31-Dec-2010

Reporting Currency:       Euro

Annual Sales:               819.2  1

Net Income:                   (16.5)

Total Assets:                 840.7  2

Market Value:                109.4

(30-Sep-2011)

 

 

Business Description     

 

Ercros SA is a Spain-based company that, along with its subsidiaries and affiliates, is engaged in the chemical industry. Its products are structured in five business lines: Basic Chemicals, including chlorine, ethyl acetate, caustic soda, sodium hypochlorite, dichloroethane, chloromethane, sodium chlorate and caustic potash, as well as water disinfectants; Intermediate Chemicals, producing glues and resins for the fiberboard and plywood industries; Plastics, focused on the production of polyvinyl chloride (PCV); Pharmaceuticals, comprising raw material and intermediate products used in the pharmaceutical industry; and Animal Feed, providing phosphates used as an additive in the manufacture of supplements and compound fodder. The Company exports its products to 125 countries, such as France, Italy, Portugal, Germany, Turkey, Belgium, Brazil, India, China and Greece. For the six months ended 30 June 2011, Ercros S.A.'s total revenue increased 24% to EUR372M. Net income from continuing operations totaled EUR6.1M, vs. a loss of EUR10.1M. Total revenue reflects an increased demand for the Company's products and services in the Business Related to Chlorine and Pharmaceutical business segments. Net income from continuing operations reflects improved operating profit margin.


Industry

 

Industry            Chemical Manufacturing

ANZSIC 2006:    1812 - Basic Organic Chemical Manufacturing

NACE 2002:      2414 - Manufacture of other organic basic chemicals

NAICS 2002:     325199 - All Other Basic Organic Chemical Manufacturing

UK SIC 2003:    2414 - Manufacture of other organic basic chemicals

US SIC 1987:    2869 - Industrial Organic Chemicals, Not Elsewhere Classified

 

           

Key Executives   

 

Name

Title

Antonio Zabalza Marti

Chairman of the Board, Chief Executive Officer

Pedro Rodriguez Sanchez

Chief Financial and Economic Officer

Teresa Conesa Fabregues

General Secretary

Eduardo Gual de Diego

Chief Information and Systems Officer

Josep Mota Balcells

Chief Technology and Innovations Officer

 

 

Significant Developments

 

Topic

#*

Most Recent Headline

Date

Divestitures / Spin-offs

1

Ercros SA Announces Sale of Its Ercros Deutschland GmbH

2-Nov-2010

 

 

 

* number of significant developments within the last 12 months   

 

 

News

 

Title

Date

Companiesandmarkets.com: Developing Economies Driving Vinyls Demand; Buoying Prospects in the Dichloroethane Market
China Weekly News (354 Words)

5-Oct-2011

Tessenderlo Chemie NV exits commodities and transforms into a global specialty group Conference Call - Final
FD (Fair Disclosure) Wire (4339 Words)

31-Aug-2011

Global Dichloroethane Market to Reach 53.8 Million Metric Tons in 2017, According to New Report by Global Industry Analysts, Inc.
PR Web (540 Words)

24-Aug-2011

Ercros posts EUR 6.14m net profit in H1 2011
ADP Spain News (110 Words)

28-Jul-2011

Spain Ercros, German Seeger to invest EUR 52.6m in bioenergy
ADP Spain News (118 Words)

6-Jun-2011

 

 

Financial summary

 

As of 30-Jun-2011

Key Ratios

Company

Industry

Current Ratio (MRQ)

0.98

2.18

Quick Ratio (MRQ)

0.78

1.35

Debt to Equity (MRQ)

0.52

0.82

Sales 5 Year Growth

3.00

6.26

 

 

Stock Snapshot

 

 

Traded: Mercado Continuo Espana: ECR

 

As of 30-Sep-2011

   Financials in: EUR

Recent Price

0.81

 

EPS

-0.14

52 Week High

1.16

 

Price/Sales

0.13

52 Week Low

0.66

 

Price/Book

0.43

Avg. Volume (mil)

0.17

 

Beta

1.03

Market Value (mil)

81.50

 

 

 

 

Price % Change

Rel S&P 500%

4 Week

-4.71%

-5.63%

13 Week

-16.92%

1.99%

52 Week

-0.86%

21.97%

Year to Date

13.45%

30.87%

 

 

Financial Data

Financials in:

EUR(mil)

 

Revenue:

618.5

Net Income:

-12.5

Assets:

626.7

Long Term Debt:

1.8

 

Total Liabilities:

434.9

 

Working Capital:

0.0

 

 

 

Date of Financial Data:

31-Dec-2010

 

1 Year Growth

2.0%

NA

-2.1%

 

Market Data

Quote Symbol:

ECR

Exchange:

Mercado Continuo Espana

Currency:

EUR

Stock Price:

0.8

Stock Price Date:

09-30-2011

52 Week Price Change %:

-0.9

Market Value (mil):

81,504.7

 

SEDOL:

B4WHFN4

ISIN:

ES0125140A14

 

Equity and Dept Distribution:

05/2007, Rights Issue, 2 new shares for every 5 shares held @ EUR 0.5 (Factor: 1.067797). 10/2009, 1-for-10 share consolidation.

 

 

Subsidiaries

Company

Percentage Owned

Country

Inmobiliaria Unión Industrial SAU

100%

SPAIN

Marcoating, S.L.U.

100%

SPAIN

Ercekol, A.I.E.

56.56%

SPAIN

Asociación Flix-Coquisa, S.L.

50%

SPAIN

Ercros France, S.A.

100%

FRANCE

Ercros Italia, S.R.L.

100%

ITALY

Ercros Portugal, S.A.

100%

PORTUGAL

Gades, Ltd.

100%

UK

Fosfatos de Cartagena, S.L.U.

100%

SPAIN

Ufefys, S.L.

60%

SPAIN

Laboratorios Busto, S.A.U.

100%

SPAIN

 

 

 

 

Shareholders

 

 

Major Shareholders

Cellex (10.25%); Bidsa (8.39%)

 

 

 

 

Key Corporate Relationships

Auditor:

Ernst & Young SA

 

Auditor:

Ernst & Young SA, BDO Audiberia Auditores SL

 

 

 

 

 

 

 

 

Corporate Family

Corporate Structure News:

 

Ercros SA

Total Corporate Family Members: 3 

 

 

Company Name

Company Type

Location

Country

Industry

Sales
(USD mil)

Employees

 

Ercros SA

Parent

Barcelona

Spain

Chemical Manufacturing

819.2

1,629

 

Ercros Industrial Sa

Subsidiary

Barcelona

Spain

Chemical Manufacturing

747.8

1,040

 

Ecronova Polymer GmbH

Subsidiary

Recklinghausen, Nordrhein-Westfalen

Germany

Fabricated Plastic and Rubber

 

50

 

 

 

 

Executive report

 

Board of Directors

 

Name

Title

Function

 

Antonio Zabalza Marti

 

Chairman of the Board, Chief Executive Officer

Chairman

 

Reuters Biography (Ercros SA)

Mr. Antonio Zabalza Marti has been Chairman of the Board and Chief Executive Officer of Ercros SA since June 14, 1996. He is also Member of the Company's Audit Committee. He also serves as Director of Aragonesas Industrias y Energia SA, Ercos Industrial SA and Fosfatos de Cartagena SL. Since 1982, he has been Professor of Economic Theory at Universidad de Valencia. Between 1984 and 2005, he served as General Director of Planning in the Spanish Treasury; Secretary General of Planning and Budgeting; Treasury Secretary of State and Director of the Prime Minister’s Office. In the past, he served as Member of the Board of Directors of Minas de Almaden and Transmediterranea from 1984 to 1987; Member of the Board of Directors of the Instituto Nacional de Industria between 1987 and 1988, and from 1993 to 1995; Member of the Board of Directors of the Instituto de Credito Oficial, between 1987 and 1993; Member of the Board of Directors of Iberia, from 1988 to 1993, as well as Member of the Board of Directors of the Instituto Nacional de Hidrocarburos, from 1993 to 1995. In 2005, he was elected Chairman of the Catalan Chemical Sector Trade Federation (Fedequim) and Vice Chairman of the Spanish Chemical Industry Trade Federation (Feique). In addition, he has acted as Consultant for the World Bank, the International Monetary Fund and the OECD. He holds a Doctorate in Philosophy degree in Economics from Universitat de Barcelona (Universidad de Barcelona), a Master of Science degree and a Doctorate in Philosophy degree, both from the London School of Economics.



PHD , University of London
PHD Economics, Universitat de Barcelona
MS , University of London


Compensation/Salary: 434,244

Ramon Blanco Balin

 

Independent Director

Director/Board Member

 

 

Reuters Biography (Ercros SA)

Mr. Ramon Blanco Balin has served as Independent Member of the Board of Directors of Ercros SA since July 29, 1996. He is also Member of the Company’s Nominating and Remuneration Committee. He acted as Inspector in the Madrid Treasury Office, from 1982 to 1985, and Assistant Inspector in the National Inspectorate, between 1985 and 1991. He has worked in the private sector since 1991 as Financial and Tax Consultant, as well as he acted as Member of the Board of Directors and the Executive Committee of Banco Zaragozano from 1992 to 1996. In addition, he has been Member of the Board of Directors, Chairman of the Audit Committee, Vice Chairman of the Board of Directors and Chief Executive Officer of Repsol YPF. In the past, he acted as Member of the Board of Directors and the Executive Committee of Gas Natural SDG and Enagas SA, from 2000 to 2005. He is currently Member of the Board of Directors of NH Hoteles SA and Chairman of its Audit Committee. He holds degree in Business and Economics from Universidad Complutense de Madrid.



Business and Economics, Universidad Complutense de Madrid


Compensation/Salary: 29,299

Josep Lluis Cabestany Illana

 

Director

Director/Board Member

 

 

Luis Fernandez-Goula Pfaff

 

Independent Director

Director/Board Member

 

 

Reuters Biography (Ercros SA)

Mr. Luis Fernandez-Goula Pfaff has served as Independent Member of the Board of Directors of Ercros SA since April 9, 2010. He is also Chairman of the Company's Nominating and Remuneration Committee. Currently, he works at Carburos Metalicos serving as General Director for South Europe, as well as he is Member of the Board of Directors of Oxigeno de Sagunto SL and Greengas SRL, President of AEGE and Member of Asociacion Espanola de Directivos. In addition, he is Member of the Catalan Chemical Sector Trade Federation (Fedequim). He holds a degree in Chemical Engineering from Instituto Quimico De Sarria and a Masters of Business Administration degree from ESADE.



MBA , ESADE
Chemical Engineering, Instituto Quimico De Sarria


Compensation/Salary: 26,294

Laureano Roldan Aguilar

 

Director

Director/Board Member

 

 

Reuters Biography (Ercros SA)

Mr. Laureano Roldan Aguilar has served as Member of the Board of Directors of Ercros SA since July 29, 1996. He is also Member of the Company’s Audit Committee. He served as Auditor in Espacontrol, Deloitte and Ernst & Young, between 1987 and 1991, and Director of the Internal Audit Department of Banco Arabe Espanol SA, between 1991 and 1993. In the past, he acted as Administrator of Grupo Torras SA, from 1993 to 1997, and has been its Director and Chief Executive Officer since 1997. In addition, he was Member of the Board of Directors of Amaya Compania de Seguros y Reaseguros SA, from 1992 to 1993; Member of the Board of Directors of Prima Inmobiliaria SA, between 1993 and 2001, as well as Member of its Audit and Control Committee from 1998 to 2001. He has been Member of the Board of Directors of Ebro Puleva since 1995. Currently, he acts as Member of the Board of Directors at Puleva Biotech SA. He holds degree in Economics and Business from ICADE at Universidad Pontificia Comillas.



Business and Economics, Universidad Pontifica Comillas


Compensation/Salary: 29,299

Eduardo Sanchez Morrondo

 

Independent Director

Director/Board Member

 

 

Reuters Biography (Ercros SA)

Mr. Eduardo Sanchez Morrondo has served as Independent Member of the Board of Directors of Ercros SA since June 18, 2004. He is also Chairman of the Company's Audit Committee. From 1975 to 1980, he acted as Professor of Chemistry at Universidad de Oviedo. Between 1980 and 2002, he worked at Dow Chemical Group, serving as Chairman and Chief Executive Officer of Dow Chemical Iberica and Dow Francia, as well as Vice Chairman of Dow Europa. He was on the Management Committee of British Petroleum Espana and since 2002, he has been the Chairman and Founder of the Bonheur Group. In addition, he has been Chairman of the Board of Directors of Bonheur Consejeros, Navec 2005, Derprocom, Creade, GloBorSan and European Security, and Member of the Board of Directors of Fargosan and Gavin Anderson. In the past, he was Chairman of the European Extruded Polystyrene Insulation Board Association (Exiba), First Vice Chairman of the Spanish Chemical Industry Trade Federation (Feique) and Member of the Executive Committee and the Organising Committee of the Expoquimia Trade Fair. He holds degree in Chemistry from Universidad de Oviedo and in 1980 he received a Doctorate of Science degree in Advanced Chemistry from the same university.



DS Chemistry, Universidad de Oviedo
Chemistry, Universidad de Oviedo


Compensation/Salary: 29,299

 

Executives

 

Name

Title

Function

 

Antonio Zabalza Marti

 

Chairman of the Board, Chief Executive Officer

Chief Executive Officer

 

Reuters Biography (Ercros SA)

Mr. Antonio Zabalza Marti has been Chairman of the Board and Chief Executive Officer of Ercros SA since June 14, 1996. He is also Member of the Company's Audit Committee. He also serves as Director of Aragonesas Industrias y Energia SA, Ercos Industrial SA and Fosfatos de Cartagena SL. Since 1982, he has been Professor of Economic Theory at Universidad de Valencia. Between 1984 and 2005, he served as General Director of Planning in the Spanish Treasury; Secretary General of Planning and Budgeting; Treasury Secretary of State and Director of the Prime Minister’s Office. In the past, he served as Member of the Board of Directors of Minas de Almaden and Transmediterranea from 1984 to 1987; Member of the Board of Directors of the Instituto Nacional de Industria between 1987 and 1988, and from 1993 to 1995; Member of the Board of Directors of the Instituto de Credito Oficial, between 1987 and 1993; Member of the Board of Directors of Iberia, from 1988 to 1993, as well as Member of the Board of Directors of the Instituto Nacional de Hidrocarburos, from 1993 to 1995. In 2005, he was elected Chairman of the Catalan Chemical Sector Trade Federation (Fedequim) and Vice Chairman of the Spanish Chemical Industry Trade Federation (Feique). In addition, he has acted as Consultant for the World Bank, the International Monetary Fund and the OECD. He holds a Doctorate in Philosophy degree in Economics from Universitat de Barcelona (Universidad de Barcelona), a Master of Science degree and a Doctorate in Philosophy degree, both from the London School of Economics.



PHD , University of London
PHD Economics, Universitat de Barcelona
MS , University of London


Compensation/Salary: 434,244

Jesús Collantes Vivancos

 

Director General Adjunto a la Presidencia

President

 

 

Pere Balcells Sagarra

 

Manager, Water Treatment Division

Division Head Executive

 

 

Maria del Carmen Cruzado Rodriguez

 

Director of the Pharmaceuticals Division

Division Head Executive

 

 

Jose Miguel Falcon Sanz

 

Director of the Plastics Division

Division Head Executive

 

 

Francisco Garcia Bru

 

Director of the Basic Chemicals Division

Division Head Executive

 

 

Antonio Llena Estruch

 

Director of the Animal Feed Division

Division Head Executive

 

 

Peter Montag

 

Director de la División de Emulsiones

Division Head Executive

 

 

Jaume Reig Navalon

 

Director of the Intermediate Chemicals Division

Division Head Executive

 

 

Josep Rovira Pujals

 

Chief Administrative Officer

Administration Executive

 

 

Reuters Biography (Ercros SA)

Mr.Josep Rovira Pujals serves as Chief Administrative Officer of Ercros SA. He is Non-Member Secretary of the Audit Committee of the Company.

Teresa Conesa Fabregues

 

General Secretary

Company Secretary

 

 

Santiago Mayans Sintes

 

Director of Legal Affairs, Non-Member Secretary of the Board

Company Secretary

 

 

Reuters Biography (Ercros SA)

Mr. Santiago Mayans Sintes serves as Director of Legal Affairs and Non-Member Secretary of the Board of Directors of Ercros SA. Between 1990 and 1994, he served as Head of the Legal Department at Erkimia SA. From 1974 to 1989, he was Legal Advisor at Cros SA. In the past, he worked at the Legal Firms Linklaters & Paines in London, Dexeus in Barcelona, Danes y Vidal in Barcelona and Garcia Meca Firm, Barrister in Barcelona. He graduated with a Bachelors degree in Law from Universidad de Deusto and holds a specialization in Law and Economics from the same academic institution. In addition, he obtained a Masters degree in International Trade and Law from Illustre Collegi d'Advocats de Barcelona.



M International Trade, Illustre Collegi d'Advocats de Barcelona
M Law, Illustre Collegi d'Advocats de Barcelona
B Law, Universidad de Deusto

Meritxell Alberti Mendez

 

Finance Director

Finance Executive

 

 

Pedro Rodriguez Sanchez

 

Chief Financial and Economic Officer

Finance Executive

 

 

Pedro Bienes Bonet

 

Director of Planning and Control, Internal Auditor

Accounting Executive

 

 

Joaquín Sanmartín

 

Human Resources Manager

Human Resources Executive

GW 

 

Joaquin Sanmartin Muniz

 

Director of Human Resources

Human Resources Executive

 

 

Reuters Biography (Ercros SA)

Mr. Joaquin Sanmartin Muniz serves as Director of Human Resources of Ercros SA. He is also Non-Member Secretary of the Company's Nominating and Remuneration Committee.

Eduardo Gual de Diego

 

Chief Information and Systems Officer

Information Executive

 

 

Josep Mota Balcells

 

Chief Technology and Innovations Officer

Engineering/Technical Executive

 

 

Francisco Manuel Arce Montaner

 

Director of Integrated Logistics

Logistics Executive

 

 

Jose Luis Muniz Alvarez

 

General Director of Business

Other

 

 

Jose Luis Pena Penacoba

 

Director of Sustainable Development

Other

 

 

 

Significant Developments

 

Ercros SA Announces Sale of Its Ercros Deutschland GmbH Nov 02, 2010

 

Ercros SA announced that it has sold its Germany-based subsidiary Ercros Deutschland GmbH, which was active in the operation of the Company's emulsions business, at a value of EUR 9.2 million. Other details were not disclosed.

 

Ercros posts EUR 6.14m net profit in H1 2011

 

ADP Spain News

28 July 2011

 

[What follows is the full text of the news story.]

(SeeNews) - Jul 28, 2011 - Spanish chemicals group Ercros SA (MCE:ECR) posted a EUR 6.14 million (USD 8.77m) net profit in the first half of 2011, versus a loss of EUR 9.55 million registered a year ago.

 

Revenue stood at EUR 380 million, up 23.7% on the year, while earnings before interest, tax, depreciation and amortisation (EBITDA) came in at EUR 19.31 million.

 

Ercros attributed the good results to its favourable performance abroad and to costs savings. Ercros believes that the positive trend will be kept in the second half of the year as well.

 

(EUr 1.0 = USD 1.428)

 

Related Companies

Ercros, SA [profile]

 

Related Topics

Earnings & Financial Performance

Finance & Accounting Standards

Financial Markets

Mergers and Acquisitions

 

Related Industries

·         2800 Chemicals & allied products

·         2890 Miscellaneous chemical products Chemical Manufacturing [profile]

·         24300 Manufacture of paints, varnishes and similar coatings, printing ink and mastics

·         2530 Basic Chemical Manufacturing

·         2540 Other Chemical Product Manufacturing


Press clippings

 

Spain Ercros, German Seeger to invest EUR 52.6m in bioenergy

 

ADP Spain News

06 June 2011

 

[What follows is the full text of the news story.]

(ADPnews) - Jun 6, 2011 - Spanish chemical group Ercros SA (MCE:ECR) and German biomass power producer Seeger Engineering signed a deal to invest EUR 52.6 million (USD 77m) in bioenergy undertakings at Flix, in the northern region of Catalonia.

 

The two companies will build a 6-MW biomass co-generation plant and a pellet plant with an annual capacity of 100,000 tonnes, Ercros said in a statement on Friday.

 

The plants will be built close to Ercros's facility in Flix, which produces chlorine and caustic soda.

 

Currently, the technological and financial offers are being considered, Ercros noted. The construction works are expected to start in 2012 at the latest.

 

(EUR 1 = USD 1.464)

 

 

Related Companies

Ercros, SA [profile]

 

Related Industries

2800 Chemicals & allied products

2890 Miscellaneous chemical products

Chemical Manufacturing [profile]

24300 Manufacture of paints, varnishes and similar coatings, printing ink and mastics

2530 Basic Chemical Manufacturing

2540 Other Chemical Product Manufacturing

 

Ercros turns to EUR 2.96m profit in Q1 2011

 

ADP Spain News

11 May 2011

 

[What follows is the full text of the news story.]

(ADPnews) - May 11, 2011 - Spanish chemical group Ercros SA (MCE:ECR) turned to a EUR-2.96-million (USD 4.26m) profit in the first quarter of 2011 versus a loss of EUR 7.28 million posted a year ago.

 

Ercros increased its revenue by 26% year-on-year to EUR 178.43 million, the company said today in a filing with the national stock market regulator CNMV.

 

The rise in the revenue was explained with the rise in demand in the international markets as well as with the high prices.

 

The earnings before interest, tax, depreciation and amortisation (EBITDA) came in at EUR 9.51 million, against a loss before interest, tax, depreciation and amortisation (LBITDA) of EUR 1.22 million in the first quarter of 2010.

 

(EUR 1.0 = USD 1.439)

 

           

Related Companies

Ercros, SA [profile]

 

Related Topics

Earnings & Financial Performance

Finance & Accounting Standards

Financial Markets

 

Related Industries

·         2800 Chemicals & allied products

·         2890 Miscellaneous chemical products Chemical Manufacturing [profile]

·         24300 Manufacture of paints, varnishes and similar coatings, printing ink and mastics

·         2530 Basic Chemical Manufacturing

·         2540 Other Chemical Product Manufacturing

 


Annual Income Statement

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           

 

 

 

31-Dec-2010

31-Dec-2009

31-Dec-2008

31-Dec-2007

31-Dec-2006

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal
31-Dec-2010

Updated Normal 
31-Dec-2009

Restated Normal 
31-Dec-2009

Reclassified Normal 
31-Dec-2008

Reclassified Normal 
31-Dec-2007

Filed Currency

EUR

EUR

EUR

EUR

EUR

Exchange Rate (Period Average)

0.755078

0.719047

0.683679

0.730637

0.796979

Auditor

Ernst & Young SA

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Net Sales

806.9

792.5

1,220.8

1,161.4

904.7

Revenue

806.9

792.5

1,220.8

1,161.4

904.7

    Other Revenue

12.3

50.7

30.0

29.4

57.1

Other Revenue, Total

12.3

50.7

30.0

29.4

57.1

Total Revenue

819.2

843.2

1,250.7

1,190.9

961.7

 

 

 

 

 

 

    Cost of Revenue

409.9

400.5

692.7

604.8

450.5

Cost of Revenue, Total

409.9

400.5

692.7

604.8

450.5

Gross Profit

397.0

392.0

528.1

556.6

454.2

 

 

 

 

 

 

    Labor & Related Expense

117.5

147.7

155.7

186.4

136.1

Total Selling/General/Administrative Expenses

117.5

147.7

155.7

186.4

136.1

    Depreciation

25.6

23.4

57.3

56.0

50.8

Depreciation/Amortization

25.6

23.4

57.3

56.0

50.8

    Litigation

0.2

22.6

-

-

-

    Impairment-Assets Held for Use

-

-

290.0

-

-

Unusual Expense (Income)

0.2

22.6

290.0

-

-

    Other Operating Expense

277.4

313.8

341.2

361.5

304.5

Other Operating Expenses, Total

277.4

313.8

341.2

361.5

304.5

Total Operating Expense

830.6

908.0

1,537.0

1,208.7

941.9

 

 

 

 

 

 

Operating Income

-11.4

-64.8

-286.2

-17.8

19.9

 

 

 

 

 

 

        Interest Expense - Non-Operating

-0.4

-0.9

-1.8

-1.3

-1.4

    Interest Expense, Net Non-Operating

-0.4

-0.9

-1.8

-1.3

-1.4

        Interest Income - Non-Operating

0.0

0.0

0.8

32.5

1.5

        Investment Income - Non-Operating

0.3

-1.3

-1.1

-1.5

-0.1

    Interest/Investment Income - Non-Operating

0.3

-1.3

-0.3

31.0

1.4

Interest Income (Expense) - Net Non-Operating Total

-0.1

-2.1

-2.1

29.7

0.1

    Other Non-Operating Income (Expense)

-6.8

-2.4

-9.1

-57.5

-16.9

Other, Net

-6.8

-2.4

-9.1

-57.5

-16.9

Income Before Tax

-18.3

-69.4

-297.4

-45.6

3.0

 

 

 

 

 

 

Total Income Tax

0.1

1.5

0.0

0.3

-3.1

Income After Tax

-18.4

-70.9

-297.4

-45.9

6.1

 

 

 

 

 

 

    Minority Interest

-0.3

0.5

-0.5

1.0

-0.5

Net Income Before Extraord Items

-18.6

-70.4

-297.9

-44.8

5.6

    Discontinued Operations

2.1

1.6

0.4

-

-

Total Extraord Items

2.1

1.6

0.4

-

-

Net Income

-16.5

-68.8

-297.5

-44.8

5.6

 

 

 

 

 

 

Income Available to Common Excl Extraord Items

-18.6

-70.4

-297.9

-44.8

5.6

 

 

 

 

 

 

Income Available to Common Incl Extraord Items

-16.5

-68.8

-297.5

-44.8

5.6

 

 

 

 

 

 

Basic/Primary Weighted Average Shares

100.6

100.6

100.6

100.6

67.6

Basic EPS Excl Extraord Items

-0.19

-0.70

-2.96

-0.45

0.08

Basic/Primary EPS Incl Extraord Items

-0.16

-0.68

-2.96

-0.45

0.08

Dilution Adjustment

0.0

0.0

0.0

0.0

-

Diluted Net Income

-16.5

-68.8

-297.5

-44.8

5.6

Diluted Weighted Average Shares

100.6

100.6

100.6

100.6

67.6

Diluted EPS Excl Extraord Items

-0.19

-0.70

-2.96

-0.45

0.08

Diluted EPS Incl Extraord Items

-0.16

-0.68

-2.96

-0.45

0.08

Dividends per Share - Common Stock Primary Issue

0.00

0.00

0.00

0.00

0.00

Gross Dividends - Common Stock

0.0

0.0

0.0

0.0

0.0

Interest Expense, Supplemental

0.4

0.9

1.8

1.3

1.4

Depreciation, Supplemental

25.0

22.6

57.6

56.0

50.8

Total Special Items

0.2

22.6

290.0

-

-

Normalized Income Before Tax

-18.1

-46.7

-7.4

-45.6

3.0

 

 

 

 

 

 

Effect of Special Items on Income Taxes

0.1

7.9

101.5

-

-

Inc Tax Ex Impact of Sp Items

0.2

9.5

101.5

0.3

-3.1

Normalized Income After Tax

-18.2

-56.2

-108.8

-45.9

6.1

 

 

 

 

 

 

Normalized Inc. Avail to Com.

-18.5

-55.7

-109.4

-44.8

5.6

 

 

 

 

 

 

Basic Normalized EPS

-0.18

-0.55

-1.09

-0.45

0.08

Diluted Normalized EPS

-0.18

-0.55

-1.09

-0.45

0.08

Amort of Intangibles, Supplemental

0.6

0.5

0.2

-

-

Rental Expenses

13.5

16.0

17.6

-

-

Advertising Expense, Supplemental

0.6

0.9

1.1

-

-

Research & Development Exp, Supplemental

0.4

0.4

0.6

-

-

Normalized EBIT

-11.2

-42.2

3.8

-17.8

19.9

Normalized EBITDA

14.4

-19.0

61.6

38.1

70.7

    Current Tax - Total

0.3

0.2

-0.8

0.2

1.4

Current Tax - Total

0.3

0.2

-0.8

0.2

1.4

    Deferred Tax - Total

-0.2

1.3

0.8

0.1

-4.5

Deferred Tax - Total

-0.2

1.3

0.8

0.1

-4.5

Income Tax - Total

0.1

1.5

0.0

0.3

-3.1

 


Annual Balance Sheet

Financials in: USD (mil)

 

 

 

31-Dec-2010

31-Dec-2009

31-Dec-2008

31-Dec-2007

31-Dec-2006

UpdateType/Date

Updated Normal 
31-Dec-2010

Updated Normal 
31-Dec-2009

Updated Normal 
31-Dec-2008

Updated Normal 
31-Dec-2007

Updated Normal 
31-Dec-2006

Filed Currency

EUR

EUR

EUR

EUR

EUR

Exchange Rate

0.745406

0.696986

0.719399

0.683971

0.758351

Auditor

Ernst & Young SA

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Cash & Equivalents

23.4

21.0

3.0

49.3

6.2

Cash and Short Term Investments

23.4

21.0

3.0

49.3

6.2

        Accounts Receivable - Trade, Gross

224.3

217.7

309.8

42.7

29.7

        Provision for Doubtful Accounts

-14.0

-14.6

-10.5

-

-

    Trade Accounts Receivable - Net

210.4

203.1

299.3

315.7

279.9

Total Receivables, Net

210.4

203.1

299.3

315.7

279.9

    Inventories - Finished Goods

49.0

71.5

103.9

97.9

80.5

    Inventories - Other

41.6

34.7

53.2

54.5

55.1

Total Inventory

90.7

106.1

157.1

152.3

135.5

    Restricted Cash - Current

22.3

30.0

35.8

-

-

    Discontinued Operations - Current Asset

0.0

14.0

0.0

60.1

52.2

    Other Current Assets

22.9

26.3

13.3

42.1

29.2

Other Current Assets, Total

45.2

70.2

49.1

102.2

81.4

Total Current Assets

369.7

400.5

508.5

619.5

503.0

 

 

 

 

 

 

        Land/Improvements

279.6

302.6

325.8

340.3

311.6

        Machinery/Equipment

1,302.4

1,398.9

1,282.7

1,347.3

1,200.1

        Construction in Progress

21.4

31.5

50.2

23.3

26.4

        Other Property/Plant/Equipment

30.6

35.2

34.9

36.6

34.4

    Property/Plant/Equipment - Gross

1,633.9

1,768.2

1,693.6

1,747.5

1,572.5

    Accumulated Depreciation

-978.4

-1,048.9

-1,001.9

-1,007.0

-873.5

Property/Plant/Equipment - Net

655.5

719.3

691.7

740.6

699.0

Goodwill, Net

0.1

0.1

0.0

0.1

0.1

    Intangibles - Gross

24.5

23.9

24.3

21.4

21.4

    Accumulated Intangible Amortization

-11.8

-12.2

-11.8

-12.3

-11.9

Intangibles, Net

12.7

11.7

12.5

9.1

9.5

    LT Investment - Affiliate Companies

6.1

6.6

6.4

6.6

4.3

    LT Investments - Other

45.4

49.1

22.8

42.1

103.4

Long Term Investments

51.6

55.7

29.1

48.7

107.8

    Deferred Charges

-

-

-

0.8

6.3

    Deferred Income Tax - Long Term Asset

4.6

4.8

6.0

5.5

5.2

    Other Long Term Assets

-253.4

-273.6

-265.1

-36.8

-4.6

Other Long Term Assets, Total

-248.8

-268.8

-259.1

-30.4

6.9

Total Assets

840.7

918.4

982.8

1,387.5

1,326.3

 

 

 

 

 

 

Accounts Payable

190.2

195.0

187.0

215.6

212.1

Accrued Expenses

23.6

19.1

9.3

-

-

Notes Payable/Short Term Debt

0.0

0.0

0.0

0.0

0.0

Current Portion - Long Term Debt/Capital Leases

147.7

60.9

115.2

124.7

230.3

    Income Taxes Payable

-

-

-

0.0

0.2

    Discontinued Operations - Current Liability

0.0

3.1

0.0

-

-

    Other Current Liabilities

41.5

15.9

72.0

86.9

102.7

Other Current liabilities, Total

41.5

19.0

72.0

86.9

102.9

Total Current Liabilities

403.1

294.1

383.6

427.2

545.4

 

 

 

 

 

 

    Long Term Debt

1.0

103.2

101.9

113.5

160.9

    Capital Lease Obligations

1.4

2.8

1.8

3.0

1.7

Total Long Term Debt

2.4

106.0

103.7

116.5

162.6

Total Debt

150.1

166.9

219.0

241.3

393.0

 

 

 

 

 

 

    Deferred Income Tax - LT Liability

49.4

52.5

49.3

52.6

48.3

Deferred Income Tax

49.4

52.5

49.3

52.6

48.3

Minority Interest

0.6

0.4

1.8

1.3

2.6

    Reserves

57.1

90.9

70.1

100.5

82.8

    Other Long Term Liabilities

71.0

80.1

18.6

13.5

12.5

Other Liabilities, Total

128.0

171.1

88.7

114.0

95.3

Total Liabilities

583.5

624.1

627.1

711.7

854.2

 

 

 

 

 

 

    Common Stock

40.5

231.0

503.5

529.6

341.2

Common Stock

40.5

231.0

503.5

529.6

341.2

Additional Paid-In Capital

-

0.0

151.7

159.6

90.9

Retained Earnings (Accumulated Deficit)

236.9

84.8

-278.7

8.5

52.1

    Other Equity

-20.1

-21.5

-20.8

-21.9

-12.1

Other Equity, Total

-20.1

-21.5

-20.8

-21.9

-12.1

Total Equity

257.3

294.3

355.7

675.8

472.1

 

 

 

 

 

 

Total Liabilities & Shareholders’ Equity

840.7

918.4

982.8

1,387.5

1,326.3

 

 

 

 

 

 

    Shares Outstanding - Common Stock Primary Issue

100.6

100.6

100.6

100.6

76.7

Total Common Shares Outstanding

100.6

100.6

100.6

100.6

76.7

Treasury Shares - Common Stock Primary Issue

0.0

0.0

-

-

-

Employees

1,610

1,713

1,898

2,100

2,162

Accumulated Intangible Amort, Suppl.

11.8

12.2

11.9

12.3

11.9

Total Long Term Debt, Supplemental

51.6

61.2

117.9

137.0

393.0

Long Term Debt Maturing within 1 Year

50.7

59.4

113.3

124.7

230.3

Long Term Debt Maturing in Year 2

0.0

0.9

2.7

7.6

36.0

Long Term Debt Maturing in Year 3

1.0

0.4

1.0

2.8

30.9

Long Term Debt Maturing in Year 4

0.0

0.5

0.4

1.4

28.1

Long Term Debt Maturing in Year 5

0.0

0.1

0.2

0.2

27.0

Long Term Debt Maturing in 2-3 Years

1.0

1.3

3.7

10.4

66.9

Long Term Debt Maturing in 4-5 Years

0.0

0.5

0.6

1.7

55.1

Long Term Debt Matur. in Year 6 & Beyond

0.0

0.0

0.3

0.2

40.6

Total Capital Leases, Supplemental

2.8

4.3

3.7

4.4

-

Capital Lease Payments Due in Year 1

1.4

1.5

1.9

1.4

-

Capital Lease Payments Due in Year 2

0.8

1.0

0.8

1.0

-

Capital Lease Payments Due in Year 3

0.5

0.6

0.7

0.7

-

Capital Lease Payments Due in Year 4

0.1

0.3

0.3

0.7

-

Capital Lease Payments Due in 2-3 Years

1.3

1.6

1.5

1.7

-

Capital Lease Payments Due in 4-5 Years

0.1

0.3

0.3

0.7

-

Cap. Lease Pymts. Due in Year 6 & Beyond

0.0

0.9

0.0

0.6

-

Total Operating Leases, Supplemental

1.0

1.1

2.3

-

-

Operating Lease Payments Due in Year 1

1.0

1.1

1.2

-

-

Operating Lease Payments Due in Year 2

0.0

-

1.2

-

-

Operating Lease Pymts. Due in 2-3 Years

0.0

-

1.2

-

-

Oper. Lse. Pymts. Due in Year 6 & Beyond

0.0

0.0

0.0

-

-

 

 

 


Annual Cash Flows

 

Financials in: USD (mil)

 

 

 

31-Dec-2010

31-Dec-2009

31-Dec-2008

31-Dec-2007

31-Dec-2006

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal 
31-Dec-2010

Updated Normal 
31-Dec-2009

Reclassified Normal 
31-Dec-2009

Reclassified Normal 
31-Dec-2008

Reclassified Normal 
31-Dec-2007

Filed Currency

EUR

EUR

EUR

EUR

EUR

Exchange Rate (Period Average)

0.755078

0.719047

0.683679

0.730637

0.796979

Auditor

Ernst & Young SA

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

Net Income/Starting Line

-18.3

-70.9

-297.4

-45.6

19.9

    Depreciation

25.6

23.4

58.1

56.0

-

Depreciation/Depletion

25.6

23.4

58.1

56.0

-

    Amortization of Intangibles

-

-

-

-

50.8

    Amortization of Acquisition Costs

-

-

-

-

-32.9

Amortization

-

-

-

-

17.9

    Discontinued Operations

2.1

1.6

0.4

-

-

    Unusual Items

-10.6

-24.9

285.3

34.1

-

    Other Non-Cash Items

4.1

43.9

17.0

40.8

15.4

Non-Cash Items

-4.4

20.6

302.7

74.9

15.4

    Accounts Receivable

-21.0

81.8

-3.0

10.7

-11.1

    Inventories

13.1

35.4

-26.1

-3.3

-17.3

    Other Assets

1.7

-13.4

26.2

0.7

-

    Accounts Payable

-2.0

0.8

-24.3

-18.4

-40.5

    Other Liabilities

-3.3

6.1

-26.4

-22.4

-

    Other Operating Cash Flow

-5.4

-27.0

-9.9

-30.6

-2.5

Changes in Working Capital

-16.8

83.8

-63.5

-63.2

-71.4

Cash from Operating Activities

-14.0

56.9

0.0

22.0

-18.2

 

 

 

 

 

 

    Purchase of Fixed Assets

-10.7

-50.9

-56.6

-30.7

-29.0

    Purchase/Acquisition of Intangibles

0.0

-2.3

-1.1

-4.5

0.0

Capital Expenditures

-10.7

-53.2

-57.7

-35.2

-29.0

    Acquisition of Business

0.0

-1.7

0.0

-

-

    Sale of Fixed Assets

2.8

0.1

0.5

0.0

-

    Sale/Maturity of Investment

0.5

2.9

0.7

3.2

-

    Purchase of Investments

0.0

-0.8

-1.0

-2.7

-3.3

    Sale of Intangible Assets

2.1

2.9

4.8

0.0

0.4

    Other Investing Cash Flow

12.2

0.0

60.9

0.0

7.5

Other Investing Cash Flow Items, Total

17.5

3.4

65.9

0.5

4.5

Cash from Investing Activities

6.8

-49.8

8.2

-34.7

-24.5

 

 

 

 

 

 

    Other Financing Cash Flow

-

-

-

0.0

-17.3

Financing Cash Flow Items

-

-

-

0.0

-17.3

    Cash Dividends Paid - Common

-0.8

-1.7

-5.0

-

-

Total Cash Dividends Paid

-0.8

-1.7

-5.0

-

-

        Sale/Issuance of Common

-

-

0.0

188.4

-

    Common Stock, Net

-

-

0.0

188.4

-

Issuance (Retirement) of Stock, Net

-

-

0.0

188.4

-

        Long Term Debt Issued

8.5

56.0

124.3

110.8

98.8

        Long Term Debt Reduction

-2.4

-50.8

-136.0

-246.8

-35.6

    Long Term Debt, Net

6.1

5.2

-11.7

-136.0

63.3

Issuance (Retirement) of Debt, Net

6.1

5.2

-11.7

-136.0

63.3

Cash from Financing Activities

5.3

3.5

-16.6

52.4

45.9

 

 

 

 

 

 

Foreign Exchange Effects

-

-

-

-

-0.2

Net Change in Cash

-1.9

10.6

-8.5

39.7

3.0

 

 

 

 

 

 

Net Cash - Beginning Balance

47.1

38.8

49.3

6.4

2.9

Net Cash - Ending Balance

45.2

49.5

40.9

46.2

5.9

Cash Interest Paid

5.5

6.2

12.3

19.0

17.3

Cash Taxes Paid

1.0

0.0

0.2

0.2

0.2

 

 

Annual Income Statement

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           

 

 

 

31-Dec-2010

31-Dec-2009

31-Dec-2008

31-Dec-2007

31-Dec-2006

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal 
31-Dec-2010

Updated Normal 
31-Dec-2009

Restated Normal 
31-Dec-2009

Reclassified Normal 
31-Dec-2008

Reclassified Normal 
31-Dec-2007

Filed Currency

EUR

EUR

EUR

EUR

EUR

Exchange Rate (Period Average)

0.755078

0.719047

0.683679

0.730637

0.796979

Auditor

Ernst & Young SA

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Sales of Products

806.9

792.5

1,220.8

1,156.0

904.7

    Service / Income

-

-

-

5.4

-

    Other Op. Income

12.3

50.7

30.0

29.4

57.1

Total Revenue

819.2

843.2

1,250.7

1,190.9

961.7

 

 

 

 

 

 

    Gains/Stocks

12.9

-8.7

-4.1

-

-10.0

    Consumption

397.0

409.2

696.8

604.8

460.5

    Personnel Expenses

117.5

147.7

155.7

186.4

136.1

    Depreciation/Amortization

25.6

23.4

57.3

56.0

50.8

    Other Op. Expenses

277.4

313.8

341.2

361.5

304.5

    Litigation

0.2

22.6

-

-

-

    Assets Impairment

-

-

290.0

-

-

Total Operating Expense

830.6

908.0

1,537.0

1,208.7

941.9

 

 

 

 

 

 

    Interest Income

0.0

0.0

0.8

32.5

1.5

    Other Financial Income

0.6

3.9

3.9

-

1.1

    Financial Expenses

-7.4

-6.3

-12.9

-21.5

-18.0

    Interest Expense

-0.4

-0.9

-1.8

-1.3

-1.4

    FOREX, Net

0.3

-1.3

-1.1

-1.9

-0.2

    Losses/Gains Equity Meth.

-

-

-

0.4

0.1

    Assets Write-Down

-

-

-

-36.0

0.0

Net Income Before Taxes

-18.3

-69.4

-297.4

-45.6

3.0

 

 

 

 

 

 

Provision for Income Taxes

0.1

1.5

0.0

0.3

-3.1

Net Income After Taxes

-18.4

-70.9

-297.4

-45.9

6.1

 

 

 

 

 

 

    Minority Interest

-0.3

0.5

-0.5

1.0

-0.5

Net Income Before Extra. Items

-18.6

-70.4

-297.9

-44.8

5.6

    Discontinued Operations

2.1

1.6

0.4

-

-

Net Income

-16.5

-68.8

-297.5

-44.8

5.6

 

 

 

 

 

 

Income Available to Com Excl ExtraOrd

-18.6

-70.4

-297.9

-44.8

5.6

 

 

 

 

 

 

Income Available to Com Incl ExtraOrd

-16.5

-68.8

-297.5

-44.8

5.6

 

 

 

 

 

 

Basic Weighted Average Shares

100.6

100.6

100.6

100.6

67.6

Basic EPS Excluding ExtraOrdinary Items

-0.19

-0.70

-2.96

-0.45

0.08

Basic EPS Including ExtraOrdinary Item

-0.16

-0.68

-2.96

-0.45

0.08

Dilution Adjustment

0.0

0.0

0.0

0.0

-

Diluted Net Income

-16.5

-68.8

-297.5

-44.8

5.6

Diluted Weighted Average Shares

100.6

100.6

100.6

100.6

67.6

Diluted EPS Excluding ExtraOrd Items

-0.19

-0.70

-2.96

-0.45

0.08

Diluted EPS Including ExtraOrd Items

-0.16

-0.68

-2.96

-0.45

0.08

DPS-Ordinary Shares

0.00

0.00

0.00

0.00

0.00

Gross Dividends - Common Stock

0.0

0.0

0.0

0.0

0.0

Normalized Income Before Taxes

-18.1

-46.7

-7.4

-45.6

3.0

 

 

 

 

 

 

Inc Tax Ex Impact of Sp Items

0.2

9.5

101.5

0.3

-3.1

Normalized Income After Taxes

-18.2

-56.2

-108.8

-45.9

6.1

 

 

 

 

 

 

Normalized Inc. Avail to Com.

-18.5

-55.7

-109.4

-44.8

5.6

 

 

 

 

 

 

Basic Normalized EPS

-0.18

-0.55

-1.09

-0.45

0.08

Diluted Normalized EPS

-0.18

-0.55

-1.09

-0.45

0.08

Interest Expense

0.4

0.9

1.8

1.3

1.4

Depreciation

25.0

22.6

57.6

56.0

50.8

Amortization of Intangibles

0.6

0.5

0.2

-

-

Research & Development Exp, Supplemental

0.4

0.4

0.6

-

-

Rental Expense, Supplemental

13.5

16.0

17.6

-

-

Advertising Expense, Supplemental

0.6

0.9

1.1

-

-

    Current Tax, Total

0.3

0.2

-0.8

0.2

1.4

Current Tax - Total

0.3

0.2

-0.8

0.2

1.4

    Deferred Tax, Total

-0.2

1.3

0.8

0.1

-4.5

Deferred Tax - Total

-0.2

1.3

0.8

0.1

-4.5

Income Tax - Total

0.1

1.5

0.0

0.3

-3.1

 

Annual Balance Sheet

 

Financials in: USD (mil)

 

 

 

31-Dec-2010

31-Dec-2009

31-Dec-2008

31-Dec-2007

31-Dec-2006

UpdateType/Date

Updated Normal 
31-Dec-2010

Updated Normal 
31-Dec-2009

Updated Normal 
31-Dec-2008

Updated Normal 
31-Dec-2007

Updated Normal 
31-Dec-2006

Filed Currency

EUR

EUR

EUR

EUR

EUR

Exchange Rate

0.745406

0.696986

0.719399

0.683971

0.758351

Auditor

Ernst & Young SA

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Other Inventories

41.6

34.7

53.2

54.5

53.3

    Finished Goods

49.0

71.5

103.9

97.9

80.5

    Real Estate Development

-

-

-

0.0

1.8

    Accounts Rcvbl.

224.3

217.7

309.8

-

-

    Provisions

-14.0

-14.6

-10.5

-

-

    Other Receivable

-

-

-

42.7

29.7

    Accounts Receivable, Net

-

-

-

273.0

250.2

    Cash and Equivalents

23.4

21.0

3.0

49.3

6.2

    Asset Securization Fund

22.3

30.0

35.8

-

-

    Other Assets

22.9

26.3

13.3

42.1

29.2

    Assets Held for Sale

0.0

14.0

0.0

60.1

52.2

Total Current Assets

369.7

400.5

508.5

619.5

503.0

 

 

 

 

 

 

    Formation Exp.

-

-

-

0.8

6.3

    Concessions

-

-

-

6.8

5.9

    Software

-

-

-

8.9

6.3

    Right Emissions

-

-

-

5.7

9.1

    Other Intangibles

-

-

-

0.0

0.1

    Intangibles

24.5

23.9

24.3

-

-

    Amort. Intangi.

-11.8

-12.2

-11.8

-12.3

-11.9

    Provisions

-1.3

0.0

-

-5.7

0.0

    Land/Buildings

279.6

302.6

325.8

340.3

311.6

    Plant/Machine.

1,302.4

1,398.9

1,282.7

1,347.3

1,200.1

    Other Tangibles

30.6

35.2

34.9

36.6

34.4

    Work in Progress

21.4

31.5

50.2

23.3

26.4

    Depreciation

-978.4

-1,048.9

-1,001.9

-1,007.0

-873.5

    Provisions

-252.1

-273.6

-265.1

-31.0

-4.6

    Real Estate Investments

28.6

30.5

14.8

31.6

28.7

    LT Investments

16.9

18.6

7.9

10.5

74.8

    Invest./Equity

6.1

6.6

6.4

6.6

4.3

    Goodwill

0.1

0.1

0.0

0.1

0.1

    Deferred Tax

4.6

4.8

6.0

5.5

5.2

Total Assets

840.7

918.4

982.8

1,387.5

1,326.3

 

 

 

 

 

 

    Bonds

95.7

0.0

-

-

-

    Bank Loans

50.7

59.4

113.3

123.3

228.6

    Leasing Debts

1.4

1.5

1.9

1.4

1.8

    Accounts Payable

187.1

187.5

181.8

215.6

212.1

    Provisions

5.0

12.7

14.3

5.5

16.1

    Taxes

-

-

-

0.0

0.2

    Other Current Liabilities

36.5

3.2

57.8

81.4

86.6

    Suppliers of Fixed Assets

3.1

7.5

5.1

-

-

    Public Adminstration

11.8

12.5

2.8

-

-

    Unpaid Wages

11.8

6.6

6.5

-

-

    Liabilities Held for Sale

0.0

3.1

0.0

-

-

Total Current Liabilities

403.1

294.1

383.6

427.2

545.4

 

 

 

 

 

 

    Bonds

0.0

102.3

99.1

104.3

0.0

    Bank Loans

1.0

0.8

2.8

9.3

160.9

    Leasing Debts

1.4

2.8

1.8

3.0

1.7

Total Long Term Debt

2.4

106.0

103.7

116.5

162.6

 

 

 

 

 

 

    Provisions

57.1

90.9

70.1

100.5

82.8

    Minority Int.

0.6

0.4

1.8

1.3

2.6

    Deferred Tax

49.4

52.5

49.3

52.6

48.3

    Other LT Liabilities

71.0

80.1

18.6

13.5

12.5

Total Liabilities

583.5

624.1

627.1

711.7

854.2

 

 

 

 

 

 

    Share Capital

40.5

231.0

503.5

529.6

341.2

    Share Premium

-

0.0

151.7

159.6

90.9

    Legal Reserve

20.7

5.1

24.7

26.0

23.4

    Difference Reserve

0.1

0.1

0.1

0.1

0.1

    Other Reserves

233.8

151.4

-20.0

31.7

20.9

    Valuation Reserve

-1.1

-0.8

-0.8

-1.4

1.8

    Capital Increase Exp.

-20.1

-21.5

-20.8

-21.9

-12.1

    Profit & Loss

-16.7

-71.0

-282.7

-47.9

5.9

Total Equity

257.3

294.3

355.7

675.8

472.1

 

 

 

 

 

 

Total Liabilities & Shareholders' Equity

840.7

918.4

982.8

1,387.5

1,326.3

 

 

 

 

 

 

    S/O-Ordinary Shares

100.6

100.6

100.6

100.6

76.7

Total Common Shares Outstanding

100.6

100.6

100.6

100.6

76.7

T/S-Ordinary Shares

0.0

0.0

-

-

-

Accumulated Intangible Amortization

11.8

12.2

11.9

12.3

11.9

Full-Time Employees

1,610

1,713

1,898

2,100

2,162

LT Debt Maturing in 1 Year

50.7

59.4

113.3

124.7

230.3

LT Debt Maturing in 2 Years

0.0

0.9

2.7

7.6

36.0

LT Debt Maturing in 3 Years

1.0

0.4

1.0

2.8

30.9

LT Debt Maturing in 4 Years

0.0

0.5

0.4

1.4

28.1

LT Debt Maturing in 5 Years

0.0

0.1

0.2

0.2

27.0

LT Debt/ Remaining Maturities

-

0.0

0.3

0.2

40.6

Total Long Term Debt, Supplemental

51.6

61.2

117.9

137.0

393.0

Capital Leases Due Within 1 Y

1.4

1.5

1.9

1.4

-

Capital Leases Due Within 2 Y

0.8

1.0

0.8

1.0

-

Capital Leases Due Within 3 Y

0.5

0.6

0.7

0.7

-

Capital Leases Due Within 4 Y

0.1

0.3

0.3

0.7

-

Capital Leases/ Remaining Maturities

0.0

0.9

0.0

0.6

-

Total Capital Leases

2.8

4.3

3.7

4.4

-

Operating Leases within 1 Y

1.0

1.1

1.2

-

-

Operating Leases in 2 Y

0.0

-

1.2

-

-

Total Operating Leases

1.0

1.1

2.3

-

-

 

 

Annual Cash Flows

Financials in: USD (mil)

 

 

 

31-Dec-2010

31-Dec-2009

31-Dec-2008

31-Dec-2007

31-Dec-2006

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal 
31-Dec-2010

Updated Normal 
31-Dec-2009

Reclassified Normal 
31-Dec-2009

Reclassified Normal 
31-Dec-2008

Reclassified Normal 
31-Dec-2007

Filed Currency

EUR

EUR

EUR

EUR

EUR

Exchange Rate (Period Average)

0.755078

0.719047

0.683679

0.730637

0.796979

Auditor

Ernst & Young SA

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

Operating Profit / Loss

-18.3

-70.9

-297.4

-45.6

19.9

    Depreciation

25.6

23.4

58.1

56.0

-

    Value Correction on Impairments

-3.8

14.3

290.0

30.2

-

    Provisions

-1.2

37.4

5.4

36.6

15.4

    Subventions

-3.9

-4.7

-7.6

-1.9

-

    Impairment/Sale of Assets Result

-4.7

-39.3

-4.8

3.9

-

    Financial Income

-0.7

-3.9

-1.7

-32.5

-

    Financial Expense

7.8

7.2

2.9

22.8

-

    Exchange Difference

-0.3

1.3

-1.0

0.0

-

    Other Gains/Losses

2.4

6.7

19.0

15.8

-

    Negative Consolidation Difference

-

-

-

-

-32.9

    Works Fixed Assets

-

-

-

-

-2.3

    Amortization of Intangibles

-

-

-

-

50.8

    Inventories

13.1

35.4

-26.1

-3.3

-17.3

    Impairments due to Disc. Operations

-2.1

0.0

-

-

-

    Receivables

-21.0

81.8

-3.0

10.7

-11.1

    Other ST Assets

1.7

-13.4

26.2

0.7

-

    Payables

-2.0

0.8

-24.3

-18.4

-40.5

    Other ST Liabilities

-3.3

4.4

-7.0

-16.8

-

    Other LT Liabilities

0.0

1.7

-19.4

-5.5

-

    Interest Paid

-5.5

-6.2

-12.3

-19.0

-

    Interest Gained

1.1

1.2

3.0

2.3

-

    Tax Paid

-1.0

0.0

-0.2

-0.2

-0.2

    Other Payments

0.0

-21.9

0.0

-

-

    Discontinued Operations

2.1

1.6

0.4

-

-

    Miscalculous Adjustment

-

-0.1

-0.5

-13.7

-

Cash from Operating Activities

-14.0

56.9

0.0

22.0

-18.2

 

 

 

 

 

 

    Purchase of Tangibles

-10.7

-50.9

-56.6

-30.7

-29.0

    Purchase of Intangibles

0.0

-2.3

-1.1

-4.5

0.0

    Purchase of Investment

-

0.0

-0.1

0.0

-3.3

    Purchase of Business

0.0

-1.7

0.0

-

-

    Other Assets

-

-

0.0

-2.2

4.8

    Sale of Fixed Assets

2.8

0.1

0.5

0.0

-

    Purchase of Other Investment

0.0

-0.8

-0.9

-2.7

0.0

    Sale of Intangibles

2.1

2.9

4.8

0.0

0.4

    Sale of Other Investments

0.5

2.9

0.7

3.2

-

    Discontinued Operations

12.2

0.0

60.9

0.0

-

    Interest Received

-

-

-

-

2.6

    Miscalculous Adjustment

-

-

-

2.2

-

Cash from Investing Activities

6.8

-49.8

8.2

-34.7

-24.5

 

 

 

 

 

 

    Bank Loans Obtained

1.9

0.0

124.3

13.2

98.8

    Bank Loans Repaid

0.0

-50.8

-136.0

-246.8

-35.6

    Other Debt Issuance

6.5

56.0

0.0

-

-

    Other Debt Repaid

-2.4

-

-

-

-

    Increase of Capital

-

-

0.0

188.4

-

    Capital Premium

-

-

-

0.0

-

    Interest Received

-

-

-

-

0.0

    Interest Paid

-

-

-

-

-17.3

    Bonds Emission

-

-

-

97.6

-

    Dividends Paid

-0.8

-1.7

-5.0

-

-

    Adjustment

-

-

-

-

0.0

Cash from Financing Activities

5.3

3.5

-16.6

52.4

45.9

 

 

 

 

 

 

Foreign Exchange Effects

-

-

-

-

-0.2

Net Change in Cash

-1.9

10.6

-8.5

39.7

3.0

 

 

 

 

 

 

Net Cash-Beginning Balance

47.1

38.8

49.3

6.4

2.9

Net Cash-Ending Balance

45.2

49.5

40.9

46.2

5.9

    Cash Interest Paid

5.5

6.2

12.3

19.0

17.3

    Cash Taxes Paid

1.0

0.0

0.2

0.2

0.2

 

 

Financial Health

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           

Key Indicators USD (mil)

 

Quarter
Ending
30-Jun-2011

Quarter
Ending
Yr Ago

Annual
Year End
31-Dec-2010

1 Year
Growth

3 Year
Growth

5 Year
Growth

Total Revenue1 

521.3

-

819.2

2.02%

-10.75%

3.00%

Operating Income1 

14.1

-

-11.4

-

-

-

Income Available to Common Excl Extraord Items1 

8.6

-

-18.6

-

-

-

Basic EPS Excl Extraord Items1 

0.09

-

-0.19

-

-

-

Capital Expenditures2 

3.2

-

10.7

-78.87%

-32.01%

-11.50%

Cash from Operating Activities2 

39.4

-

-14.0

-

-

-

Free Cash Flow 

37.4

-

-25.0

-

-

-

Total Assets3 

966.5

2.50%

840.7

-2.09%

-12.92%

-3.83%

Total Liabilities3 

678.4

2.50%

583.5

-0.01%

-3.69%

-3.15%

Total Long Term Debt3 

1.3

-48.00%

2.4

-97.60%

-71.89%

-58.30%

Employees3 

-

-

1610

-6.01%

-8.48%

-2.70%

Total Common Shares Outstanding3 

100.6

0.00%

100.6

0.00%

0.00%

10.01%

1-ExchangeRate: EUR to USD Average for Period

0.713558

 

0.755078

 

 

 

2-ExchangeRate: EUR to USD Average for Period

0.713558

 

0.755078

 

 

 

3-ExchangeRate: EUR to USD Period End Date

0.689727

 

0.745406

 

 

 

Utility Industry Specific USD (mil)

 

31-Dec-2007

31-Dec-2006

 

 

 

 

Deferred Charges3 

0.8

6.3

 

 

 

 

3-ExchangeRate: EUR to USD Period End Date

0.683971

0.758351

 

 

 

 

Key Ratios

 

31-Dec-2010

31-Dec-2009

31-Dec-2008

31-Dec-2007

31-Dec-2006

Profitability

Gross Margin 

49.20%

49.46%

43.26%

47.92%

50.20%

Operating Margin 

-1.40%

-7.69%

-22.89%

-1.50%

2.07%

Pretax Margin 

-2.23%

-8.23%

-23.78%

-3.83%

0.31%

Net Profit Margin 

-2.28%

-8.35%

-23.82%

-3.77%

0.58%

Financial Strength

Current Ratio 

0.92

1.36

1.33

1.45

0.92

Long Term Debt/Equity 

0.01

0.36

0.29

0.17

0.34

Total Debt/Equity 

0.58

0.57

0.62

0.36

0.83

Management Effectiveness

Return on Assets 

-2.19%

-7.57%

-24.55%

-3.43%

0.55%

Return on Equity 

-7.10%

-21.97%

-56.72%

-7.99%

1.46%

Efficiency

Receivables Turnover 

4.15

3.40

3.97

4.06

4.24

Inventory Turnover 

4.37

3.08

4.36

4.27

4.15

Asset Turnover 

0.98

0.90

1.03

0.89

0.87

Market Valuation USD (mil)

Enterprise Value2 

185.4

.

Enterprise Value/Revenue (TTM) 

0.29

Price/Book (MRQ) 

0.41

.

Enterprise Value/EBITDA (TTM) 

16.53

Market Cap as of 30-Sep-20111 

109.4

.

 

 

1-ExchangeRate: EUR to USD on 30-Sep-2011

0.745323

 

 

 

2-ExchangeRate: EUR to USD on 30-Jun-2011

0.689727

 

 

 

 

 

 

Annual Ratios

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           


 

31-Dec-2010

31-Dec-2009

31-Dec-2008

31-Dec-2007

31-Dec-2006

Financial Strength

Current Ratio 

0.92

1.36

1.33

1.45

0.92

Quick/Acid Test Ratio 

0.58

0.76

0.79

0.85

0.52

Working Capital1 

-33.4

106.4

125.0

192.3

-42.4

Long Term Debt/Equity 

0.01

0.36

0.29

0.17

0.34

Total Debt/Equity 

0.58

0.57

0.62

0.36

0.83

Long Term Debt/Total Capital 

0.01

0.23

0.18

0.13

0.19

Total Debt/Total Capital 

0.37

0.36

0.38

0.26

0.45

Payout Ratio 

0.00%

0.00%

0.00%

0.00%

0.00%

Effective Tax Rate 

-

-

-

-

-101.24%

Total Capital1 

407.4

461.2

574.7

917.1

865.0

 

 

 

 

 

 

Efficiency

Asset Turnover 

0.98

0.90

1.03

0.89

0.87

Inventory Turnover 

4.37

3.08

4.36

4.27

4.15

Days In Inventory 

83.48

118.49

83.69

85.47

87.86

Receivables Turnover 

4.15

3.40

3.97

4.06

4.24

Days Receivables Outstanding 

88.02

107.42

92.04

89.80

86.17

Revenue/Employee2 

515,397

507,808

626,262

605,769

467,486

Operating Income/Employee2 

-7,191

-39,056

-143,326

-9,072

9,655

EBITDA/Employee2 

8,891

-25,102

-114,368

19,397

34,345

 

 

 

 

 

 

Profitability

Gross Margin 

49.20%

49.46%

43.26%

47.92%

50.20%

Operating Margin 

-1.40%

-7.69%

-22.89%

-1.50%

2.07%

EBITDA Margin 

1.73%

-4.94%

-18.26%

3.20%

7.35%

EBIT Margin 

-1.40%

-7.69%

-22.89%

-1.50%

2.07%

Pretax Margin 

-2.23%

-8.23%

-23.78%

-3.83%

0.31%

Net Profit Margin 

-2.28%

-8.35%

-23.82%

-3.77%

0.58%

COGS/Revenue 

50.04%

47.50%

55.38%

50.79%

46.84%

SG&A Expense/Revenue 

14.34%

17.51%

12.45%

15.65%

14.15%

 

 

 

 

 

 

Management Effectiveness

Return on Assets 

-2.19%

-7.57%

-24.55%

-3.43%

0.55%

Return on Equity 

-7.10%

-21.97%

-56.72%

-7.99%

1.46%

 

 

 

 

 

 

Valuation

Free Cash Flow/Share2 

-0.25

0.04

-0.55

-0.14

-0.65

Operating Cash Flow/Share 2 

-0.14

0.58

0.00

0.23

-0.25

1-ExchangeRate: EUR to USD Period End Date

0.745406

0.696986

0.719399

0.683971

0.758351

2-ExchangeRate: EUR to USD Average for Period

0.745406

0.696986

0.719399

0.683971

0.758351

 

Current Market Multiples

Market Cap/Equity (MRQ) 

0.41

Enterprise Value/Equity (MRQ) 

0.64

 

 

Annual Income Statement

Standardized

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           

 

 

 

31-Dec-2010

31-Dec-2009

31-Dec-2008

31-Dec-2007

31-Dec-2006

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal
31-Dec-2010

Updated Normal 
31-Dec-2009

Restated Normal 
31-Dec-2009

Reclassified Normal 
31-Dec-2008

Reclassified Normal 
31-Dec-2007

Filed Currency

EUR

EUR

EUR

EUR

EUR

Exchange Rate (Period Average)

0.755078

0.719047

0.683679

0.730637

0.796979

Auditor

Ernst & Young SA

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Net Sales

806.9

792.5

1,220.8

1,161.4

904.7

Revenue

806.9

792.5

1,220.8

1,161.4

904.7

    Other Revenue

12.3

50.7

30.0

29.4

57.1

Other Revenue, Total

12.3

50.7

30.0

29.4

57.1

Total Revenue

819.2

843.2

1,250.7

1,190.9

961.7

 

 

 

 

 

 

    Cost of Revenue

409.9

400.5

692.7

604.8

450.5

Cost of Revenue, Total

409.9

400.5

692.7

604.8

450.5

Gross Profit

397.0

392.0

528.1

556.6

454.2

 

 

 

 

 

 

    Labor & Related Expense

117.5

147.7

155.7

186.4

136.1

Total Selling/General/Administrative Expenses

117.5

147.7

155.7

186.4

136.1

    Depreciation

25.6

23.4

57.3

56.0

50.8

Depreciation/Amortization

25.6

23.4

57.3

56.0

50.8

    Litigation

0.2

22.6

-

-

-

    Impairment-Assets Held for Use

-

-

290.0

-

-

Unusual Expense (Income)

0.2

22.6

290.0

-

-

    Other Operating Expense

277.4

313.8

341.2

361.5

304.5

Other Operating Expenses, Total

277.4

313.8

341.2

361.5

304.5

Total Operating Expense

830.6

908.0

1,537.0

1,208.7

941.9

 

 

 

 

 

 

Operating Income

-11.4

-64.8

-286.2

-17.8

19.9

 

 

 

 

 

 

        Interest Expense - Non-Operating

-0.4

-0.9

-1.8

-1.3

-1.4

    Interest Expense, Net Non-Operating

-0.4

-0.9

-1.8

-1.3

-1.4

        Interest Income - Non-Operating

0.0

0.0

0.8

32.5

1.5

        Investment Income - Non-Operating

0.3

-1.3

-1.1

-1.5

-0.1

    Interest/Investment Income - Non-Operating

0.3

-1.3

-0.3

31.0

1.4

Interest Income (Expense) - Net Non-Operating Total

-0.1

-2.1

-2.1

29.7

0.1

    Other Non-Operating Income (Expense)

-6.8

-2.4

-9.1

-57.5

-16.9

Other, Net

-6.8

-2.4

-9.1

-57.5

-16.9

Income Before Tax

-18.3

-69.4

-297.4

-45.6

3.0

 

 

 

 

 

 

Total Income Tax

0.1

1.5

0.0

0.3

-3.1

Income After Tax

-18.4

-70.9

-297.4

-45.9

6.1

 

 

 

 

 

 

    Minority Interest

-0.3

0.5

-0.5

1.0

-0.5

Net Income Before Extraord Items

-18.6

-70.4

-297.9

-44.8

5.6

    Discontinued Operations

2.1

1.6

0.4

-

-

Total Extraord Items

2.1

1.6

0.4

-

-

Net Income

-16.5

-68.8

-297.5

-44.8

5.6

 

 

 

 

 

 

Income Available to Common Excl Extraord Items

-18.6

-70.4

-297.9

-44.8

5.6

 

 

 

 

 

 

Income Available to Common Incl Extraord Items

-16.5

-68.8

-297.5

-44.8

5.6

 

 

 

 

 

 

Basic/Primary Weighted Average Shares

100.6

100.6

100.6

100.6

67.6

Basic EPS Excl Extraord Items

-0.19

-0.70

-2.96

-0.45

0.08

Basic/Primary EPS Incl Extraord Items

-0.16

-0.68

-2.96

-0.45

0.08

Dilution Adjustment

0.0

0.0

0.0

0.0

-

Diluted Net Income

-16.5

-68.8

-297.5

-44.8

5.6

Diluted Weighted Average Shares

100.6

100.6

100.6

100.6

67.6

Diluted EPS Excl Extraord Items

-0.19

-0.70

-2.96

-0.45

0.08

Diluted EPS Incl Extraord Items

-0.16

-0.68

-2.96

-0.45

0.08

Dividends per Share - Common Stock Primary Issue

0.00

0.00

0.00

0.00

0.00

Gross Dividends - Common Stock

0.0

0.0

0.0

0.0

0.0

Interest Expense, Supplemental

0.4

0.9

1.8

1.3

1.4

Depreciation, Supplemental

25.0

22.6

57.6

56.0

50.8

Total Special Items

0.2

22.6

290.0

-

-

Normalized Income Before Tax

-18.1

-46.7

-7.4

-45.6

3.0

 

 

 

 

 

 

Effect of Special Items on Income Taxes

0.1

7.9

101.5

-

-

Inc Tax Ex Impact of Sp Items

0.2

9.5

101.5

0.3

-3.1

Normalized Income After Tax

-18.2

-56.2

-108.8

-45.9

6.1

 

 

 

 

 

 

Normalized Inc. Avail to Com.

-18.5

-55.7

-109.4

-44.8

5.6

 

 

 

 

 

 

Basic Normalized EPS

-0.18

-0.55

-1.09

-0.45

0.08

Diluted Normalized EPS

-0.18

-0.55

-1.09

-0.45

0.08

Amort of Intangibles, Supplemental

0.6

0.5

0.2

-

-

Rental Expenses

13.5

16.0

17.6

-

-

Advertising Expense, Supplemental

0.6

0.9

1.1

-

-

Research & Development Exp, Supplemental

0.4

0.4

0.6

-

-

Normalized EBIT

-11.2

-42.2

3.8

-17.8

19.9

Normalized EBITDA

14.4

-19.0

61.6

38.1

70.7

    Current Tax - Total

0.3

0.2

-0.8

0.2

1.4

Current Tax - Total

0.3

0.2

-0.8

0.2

1.4

    Deferred Tax - Total

-0.2

1.3

0.8

0.1

-4.5

Deferred Tax - Total

-0.2

1.3

0.8

0.1

-4.5

Income Tax - Total

0.1

1.5

0.0

0.3

-3.1

 

 

Interim Income Statement

Standardized

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           

 

 

 

30-Jun-2011

31-Dec-2010

30-Sep-2010

30-Jun-2010

Period Length

6 Months

6 Months

9 Months

6 Months

UpdateType/Date

Updated Normal 
30-Jun-2011

Updated Normal 
31-Dec-2010

Updated Special 
30-Sep-2010

Updated Normal 
30-Jun-2010

Filed Currency

EUR

EUR

EUR

EUR

Exchange Rate (Period Average)

0.713558

0.75577

0.761121

0.754409

 

 

 

 

 

    Net Sales

511.5

415.1

595.0

391.7

Revenue

511.5

415.1

595.0

391.7

    Other Revenue

9.7

5.5

18.6

6.7

Other Revenue, Total

9.7

5.5

18.6

6.7

Total Revenue

521.3

420.7

613.6

398.4

 

 

 

 

 

    Cost of Revenue

275.9

211.1

448.4

198.8

Cost of Revenue, Total

275.9

211.1

448.4

198.8

Gross Profit

235.6

204.1

146.6

192.9

 

 

 

 

 

    Labor & Related Expense

60.2

58.8

85.9

58.6

Total Selling/General/Administrative Expenses

60.2

58.8

85.9

58.6

    Depreciation

13.0

12.3

19.7

13.3

Depreciation/Amortization

13.0

12.3

19.7

13.3

    Loss (Gain) on Sale of Assets - Operating

-

-

0.0

-

Unusual Expense (Income)

-

-

0.0

-

    Other Operating Expense

158.1

138.2

71.1

139.4

Other Operating Expenses, Total

158.1

138.2

71.1

139.4

Total Operating Expense

507.2

420.4

625.1

410.2

 

 

 

 

 

Operating Income

14.1

0.3

-11.5

-11.7

 

 

 

 

 

        Investment Income - Non-Operating

0.5

-1.2

-

1.5

    Interest/Investment Income - Non-Operating

0.5

-1.2

-

1.5

Interest Income (Expense) - Net Non-Operating Total

0.5

-1.2

-

1.5

    Other Non-Operating Income (Expense)

-5.8

-4.1

-2.9

-3.1

Other, Net

-5.8

-4.1

-2.9

-3.1

Income Before Tax

8.7

-5.0

-14.3

-13.3

 

 

 

 

 

Total Income Tax

0.0

0.1

-0.1

-0.1

Income After Tax

8.7

-5.1

-14.3

-13.3

 

 

 

 

 

    Minority Interest

-0.1

-0.1

-0.3

-0.1

Net Income Before Extraord Items

8.6

-5.3

-14.5

-13.4

    Discontinued Operations

0.0

1.4

-

0.7

Total Extraord Items

0.0

1.4

-

0.7

Net Income

8.6

-3.9

-14.5

-12.7

 

 

 

 

 

Income Available to Common Excl Extraord Items

8.6

-5.3

-14.5

-13.4

 

 

 

 

 

Income Available to Common Incl Extraord Items

8.6

-3.9

-14.5

-12.7

 

 

 

 

 

Basic/Primary Weighted Average Shares

100.6

100.6

100.6

100.6

Basic EPS Excl Extraord Items

0.09

-0.05

-0.14

-0.13

Basic/Primary EPS Incl Extraord Items

0.09

-0.04

-0.14

-0.13

Dilution Adjustment

-

0.0

0.0

0.0

Diluted Net Income

8.6

-3.9

-14.5

-12.7

Diluted Weighted Average Shares

100.6

100.6

100.6

100.6

Diluted EPS Excl Extraord Items

0.09

-0.05

-0.14

-0.13

Diluted EPS Incl Extraord Items

0.09

-0.04

-0.14

-0.13

Dividends per Share - Common Stock Primary Issue

0.00

0.00

0.00

0.00

Gross Dividends - Common Stock

0.0

0.0

0.0

0.0

Depreciation, Supplemental

13.0

12.3

19.7

13.3

Total Special Items

-

-

0.0

-

Normalized Income Before Tax

8.7

-5.0

-14.3

-13.3

 

 

 

 

 

Effect of Special Items on Income Taxes

-

-

0.0

-

Inc Tax Ex Impact of Sp Items

0.0

0.1

-0.1

-0.1

Normalized Income After Tax

8.7

-5.1

-14.3

-13.3

 

 

 

 

 

Normalized Inc. Avail to Com.

8.6

-5.3

-14.5

-13.4

 

 

 

 

 

Basic Normalized EPS

0.09

-0.05

-0.14

-0.13

Diluted Normalized EPS

0.09

-0.05

-0.14

-0.13

Rental Expenses

6.6

6.0

-

7.5

Advertising Expense, Supplemental

0.3

0.3

-

0.4

Normalized EBIT

14.1

0.3

-11.5

-11.7

Normalized EBITDA

27.1

12.6

8.3

1.5

 

 

Annual Balance Sheet

Standardized

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           

 

 

 

31-Dec-2010

31-Dec-2009

31-Dec-2008

31-Dec-2007

31-Dec-2006

UpdateType/Date

Updated Normal 
31-Dec-2010

Updated Normal 
31-Dec-2009

Updated Normal 
31-Dec-2008

Updated Normal 
31-Dec-2007

Updated Normal 
31-Dec-2006

Filed Currency

EUR

EUR

EUR

EUR

EUR

Exchange Rate

0.745406

0.696986

0.719399

0.683971

0.758351

Auditor

Ernst & Young SA

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Cash & Equivalents

23.4

21.0

3.0

49.3

6.2

Cash and Short Term Investments

23.4

21.0

3.0

49.3

6.2

        Accounts Receivable - Trade, Gross

224.3

217.7

309.8

42.7

29.7

        Provision for Doubtful Accounts

-14.0

-14.6

-10.5

-

-

    Trade Accounts Receivable - Net

210.4

203.1

299.3

315.7

279.9

Total Receivables, Net

210.4

203.1

299.3

315.7

279.9

    Inventories - Finished Goods

49.0

71.5

103.9

97.9

80.5

    Inventories - Other

41.6

34.7

53.2

54.5

55.1

Total Inventory

90.7

106.1

157.1

152.3

135.5

    Restricted Cash - Current

22.3

30.0

35.8

-

-

    Discontinued Operations - Current Asset

0.0

14.0

0.0

60.1

52.2

    Other Current Assets

22.9

26.3

13.3

42.1

29.2

Other Current Assets, Total

45.2

70.2

49.1

102.2

81.4

Total Current Assets

369.7

400.5

508.5

619.5

503.0

 

 

 

 

 

 

        Land/Improvements

279.6

302.6

325.8

340.3

311.6

        Machinery/Equipment

1,302.4

1,398.9

1,282.7

1,347.3

1,200.1

        Construction in Progress

21.4

31.5

50.2

23.3

26.4

        Other Property/Plant/Equipment

30.6

35.2

34.9

36.6

34.4

    Property/Plant/Equipment - Gross

1,633.9

1,768.2

1,693.6

1,747.5

1,572.5

    Accumulated Depreciation

-978.4

-1,048.9

-1,001.9

-1,007.0

-873.5

Property/Plant/Equipment - Net

655.5

719.3

691.7

740.6

699.0

Goodwill, Net

0.1

0.1

0.0

0.1

0.1

    Intangibles - Gross

24.5

23.9

24.3

21.4

21.4

    Accumulated Intangible Amortization

-11.8

-12.2

-11.8

-12.3

-11.9

Intangibles, Net

12.7

11.7

12.5

9.1

9.5

    LT Investment - Affiliate Companies

6.1

6.6

6.4

6.6

4.3

    LT Investments - Other

45.4

49.1

22.8

42.1

103.4

Long Term Investments

51.6

55.7

29.1

48.7

107.8

    Deferred Charges

-

-

-

0.8

6.3

    Deferred Income Tax - Long Term Asset

4.6

4.8

6.0

5.5

5.2

    Other Long Term Assets

-253.4

-273.6

-265.1

-36.8

-4.6

Other Long Term Assets, Total

-248.8

-268.8

-259.1

-30.4

6.9

Total Assets

840.7

918.4

982.8

1,387.5

1,326.3

 

 

 

 

 

 

Accounts Payable

190.2

195.0

187.0

215.6

212.1

Accrued Expenses

23.6

19.1

9.3

-

-

Notes Payable/Short Term Debt

0.0

0.0

0.0

0.0

0.0

Current Portion - Long Term Debt/Capital Leases

147.7

60.9

115.2

124.7

230.3

    Income Taxes Payable

-

-

-

0.0

0.2

    Discontinued Operations - Current Liability

0.0

3.1

0.0

-

-

    Other Current Liabilities

41.5

15.9

72.0

86.9

102.7

Other Current liabilities, Total

41.5

19.0

72.0

86.9

102.9

Total Current Liabilities

403.1

294.1

383.6

427.2

545.4

 

 

 

 

 

 

    Long Term Debt

1.0

103.2

101.9

113.5

160.9

    Capital Lease Obligations

1.4

2.8

1.8

3.0

1.7

Total Long Term Debt

2.4

106.0

103.7

116.5

162.6

Total Debt

150.1

166.9

219.0

241.3

393.0

 

 

 

 

 

 

    Deferred Income Tax - LT Liability

49.4

52.5

49.3

52.6

48.3

Deferred Income Tax

49.4

52.5

49.3

52.6

48.3

Minority Interest

0.6

0.4

1.8

1.3

2.6

    Reserves

57.1

90.9

70.1

100.5

82.8

    Other Long Term Liabilities

71.0

80.1

18.6

13.5

12.5

Other Liabilities, Total

128.0

171.1

88.7

114.0

95.3

Total Liabilities

583.5

624.1

627.1

711.7

854.2

 

 

 

 

 

 

    Common Stock

40.5

231.0

503.5

529.6

341.2

Common Stock

40.5

231.0

503.5

529.6

341.2

Additional Paid-In Capital

-

0.0

151.7

159.6

90.9

Retained Earnings (Accumulated Deficit)

236.9

84.8

-278.7

8.5

52.1

    Other Equity

-20.1

-21.5

-20.8

-21.9

-12.1

Other Equity, Total

-20.1

-21.5

-20.8

-21.9

-12.1

Total Equity

257.3

294.3

355.7

675.8

472.1

 

 

 

 

 

 

Total Liabilities & Shareholders’ Equity

840.7

918.4

982.8

1,387.5

1,326.3

 

 

 

 

 

 

    Shares Outstanding - Common Stock Primary Issue

100.6

100.6

100.6

100.6

76.7

Total Common Shares Outstanding

100.6

100.6

100.6

100.6

76.7

Treasury Shares - Common Stock Primary Issue

0.0

0.0

-

-

-

Employees

1,610

1,713

1,898

2,100

2,162

Accumulated Intangible Amort, Suppl.

11.8

12.2

11.9

12.3

11.9

Total Long Term Debt, Supplemental

51.6

61.2

117.9

137.0

393.0

Long Term Debt Maturing within 1 Year

50.7

59.4

113.3

124.7

230.3

Long Term Debt Maturing in Year 2

0.0

0.9

2.7

7.6

36.0

Long Term Debt Maturing in Year 3

1.0

0.4

1.0

2.8

30.9

Long Term Debt Maturing in Year 4

0.0

0.5

0.4

1.4

28.1

Long Term Debt Maturing in Year 5

0.0

0.1

0.2

0.2

27.0

Long Term Debt Maturing in 2-3 Years

1.0

1.3

3.7

10.4

66.9

Long Term Debt Maturing in 4-5 Years

0.0

0.5

0.6

1.7

55.1

Long Term Debt Matur. in Year 6 & Beyond

0.0

0.0

0.3

0.2

40.6

Total Capital Leases, Supplemental

2.8

4.3

3.7

4.4

-

Capital Lease Payments Due in Year 1

1.4

1.5

1.9

1.4

-

Capital Lease Payments Due in Year 2

0.8

1.0

0.8

1.0

-

Capital Lease Payments Due in Year 3

0.5

0.6

0.7

0.7

-

Capital Lease Payments Due in Year 4

0.1

0.3

0.3

0.7

-

Capital Lease Payments Due in 2-3 Years

1.3

1.6

1.5

1.7

-

Capital Lease Payments Due in 4-5 Years

0.1

0.3

0.3

0.7

-

Cap. Lease Pymts. Due in Year 6 & Beyond

0.0

0.9

0.0

0.6

-

Total Operating Leases, Supplemental

1.0

1.1

2.3

-

-

Operating Lease Payments Due in Year 1

1.0

1.1

1.2

-

-

Operating Lease Payments Due in Year 2

0.0

-

1.2

-

-

Operating Lease Pymts. Due in 2-3 Years

0.0

-

1.2

-

-

Oper. Lse. Pymts. Due in Year 6 & Beyond

0.0

0.0

0.0

-

-

 

 

Interim Balance Sheet

Standardized

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           

 

 

 

30-Jun-2011

31-Mar-2011

31-Dec-2010

30-Jun-2010

31-Dec-2009

UpdateType/Date

Updated Normal 
30-Jun-2011

Updated Normal 
31-Mar-2011

Updated Normal 
31-Dec-2010

Updated Normal 
30-Jun-2010

Updated Normal 
31-Dec-2009

Filed Currency

EUR

EUR

EUR

EUR

EUR

Exchange Rate

0.689727

0.704672

0.745406

0.816393

0.696986

 

 

 

 

 

 

    Cash & Equivalents

84.1

-

45.7

47.0

51.0

Cash and Short Term Investments

84.1

-

45.7

47.0

51.0

    Trade Accounts Receivable - Net

261.2

-

210.4

195.2

203.1

Total Receivables, Net

261.2

-

210.4

195.2

203.1

Total Inventory

95.2

-

90.7

80.5

106.1

    Discontinued Operations - Current Asset

-

-

0.0

15.2

14.0

    Other Current Assets

24.6

0.4

22.9

22.5

26.3

Other Current Assets, Total

24.6

0.4

22.9

37.7

40.3

Total Current Assets

465.0

0.4

369.7

360.4

400.5

 

 

 

 

 

 

Property/Plant/Equipment - Net

428.2

-

403.5

372.7

445.6

Intangibles, Net

11.0

-

11.4

12.3

11.8

    LT Investment - Affiliate Companies

8.3

-

6.1

5.6

6.6

    LT Investments - Other

49.1

-

45.4

41.4

49.1

Long Term Investments

57.4

-

51.6

47.0

55.7

    Deferred Income Tax - Long Term Asset

4.9

-

4.6

4.3

4.8

    Other Long Term Assets

-

0.5

-

-

-

Other Long Term Assets, Total

4.9

0.5

4.6

4.3

4.8

Total Assets

966.5

0.9

840.7

796.7

918.4

 

 

 

 

 

 

Accounts Payable

252.7

-

187.1

179.0

187.5

Notes Payable/Short Term Debt

0.0

0.0

0.0

0.0

0.0

Current Portion - Long Term Debt/Capital Leases

149.2

-

147.7

55.7

60.9

    Discontinued Operations - Current Liability

-

-

0.0

5.2

3.1

    Other Current Liabilities

71.8

0.5

68.2

142.4

42.6

Other Current liabilities, Total

71.8

0.5

68.2

147.6

45.7

Total Current Liabilities

473.6

0.5

403.1

382.2

294.1

 

 

 

 

 

 

    Long Term Debt

1.3

-

2.4

2.1

106.0

Total Long Term Debt

1.3

0.0

2.4

2.1

106.0

Total Debt

150.5

0.0

150.1

57.8

166.9

 

 

 

 

 

 

    Deferred Income Tax - LT Liability

53.4

-

49.4

44.8

52.5

Deferred Income Tax

53.4

-

49.4

44.8

52.5

Minority Interest

0.8

0.0

0.6

0.4

0.4

    Reserves

60.0

-

57.1

58.6

90.9

    Other Long Term Liabilities

89.4

0.2

71.0

70.9

80.1

Other Liabilities, Total

149.3

0.2

128.0

129.6

171.1

Total Liabilities

678.4

0.7

583.5

559.2

624.1

 

 

 

 

 

 

    Common Stock

43.8

-

40.5

37.0

231.0

Common Stock

43.8

-

40.5

37.0

231.0

Retained Earnings (Accumulated Deficit)

266.0

-

236.9

218.9

84.8

    Other Equity

-21.7

0.3

-20.1

-18.3

-21.5

Other Equity, Total

-21.7

0.3

-20.1

-18.3

-21.5

Total Equity

288.1

0.3

257.3

237.5

294.3

 

 

 

 

 

 

Total Liabilities & Shareholders’ Equity

966.5

0.9

840.7

796.7

918.4

 

 

 

 

 

 

    Shares Outstanding - Common Stock Primary Issue

100.6

100.6

100.6

100.6

100.6

Total Common Shares Outstanding

100.6

100.6

100.6

100.6

100.6

Treasury Shares - Common Stock Primary Issue

0.0

-

0.0

0.0

0.0

Employees

1,629

-

1,610

1,692

1,713

 

 

 

Annual Cash Flows

Standardized

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           

 

 

 

31-Dec-2010

31-Dec-2009

31-Dec-2008

31-Dec-2007

31-Dec-2006

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal 
31-Dec-2010

Updated Normal 
31-Dec-2009

Reclassified Normal 
31-Dec-2009

Reclassified Normal 
31-Dec-2008

Reclassified Normal 
31-Dec-2007

Filed Currency

EUR

EUR

EUR

EUR

EUR

Exchange Rate (Period Average)

0.755078

0.719047

0.683679

0.730637

0.796979

Auditor

Ernst & Young SA

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

Net Income/Starting Line

-18.3

-70.9

-297.4

-45.6

19.9

    Depreciation

25.6

23.4

58.1

56.0

-

Depreciation/Depletion

25.6

23.4

58.1

56.0

-

    Amortization of Intangibles

-

-

-

-

50.8

    Amortization of Acquisition Costs

-

-

-

-

-32.9

Amortization

-

-

-

-

17.9

    Discontinued Operations

2.1

1.6

0.4

-

-

    Unusual Items

-10.6

-24.9

285.3

34.1

-

    Other Non-Cash Items

4.1

43.9

17.0

40.8

15.4

Non-Cash Items

-4.4

20.6

302.7

74.9

15.4

    Accounts Receivable

-21.0

81.8

-3.0

10.7

-11.1

    Inventories

13.1

35.4

-26.1

-3.3

-17.3

    Other Assets

1.7

-13.4

26.2

0.7

-

    Accounts Payable

-2.0

0.8

-24.3

-18.4

-40.5

    Other Liabilities

-3.3

6.1

-26.4

-22.4

-

    Other Operating Cash Flow

-5.4

-27.0

-9.9

-30.6

-2.5

Changes in Working Capital

-16.8

83.8

-63.5

-63.2

-71.4

Cash from Operating Activities

-14.0

56.9

0.0

22.0

-18.2

 

 

 

 

 

 

    Purchase of Fixed Assets

-10.7

-50.9

-56.6

-30.7

-29.0

    Purchase/Acquisition of Intangibles

0.0

-2.3

-1.1

-4.5

0.0

Capital Expenditures

-10.7

-53.2

-57.7

-35.2

-29.0

    Acquisition of Business

0.0

-1.7

0.0

-

-

    Sale of Fixed Assets

2.8

0.1

0.5

0.0

-

    Sale/Maturity of Investment

0.5

2.9

0.7

3.2

-

    Purchase of Investments

0.0

-0.8

-1.0

-2.7

-3.3

    Sale of Intangible Assets

2.1

2.9

4.8

0.0

0.4

    Other Investing Cash Flow

12.2

0.0

60.9

0.0

7.5

Other Investing Cash Flow Items, Total

17.5

3.4

65.9

0.5

4.5

Cash from Investing Activities

6.8

-49.8

8.2

-34.7

-24.5

 

 

 

 

 

 

    Other Financing Cash Flow

-

-

-

0.0

-17.3

Financing Cash Flow Items

-

-

-

0.0

-17.3

    Cash Dividends Paid - Common

-0.8

-1.7

-5.0

-

-

Total Cash Dividends Paid

-0.8

-1.7

-5.0

-

-

        Sale/Issuance of Common

-

-

0.0

188.4

-

    Common Stock, Net

-

-

0.0

188.4

-

Issuance (Retirement) of Stock, Net

-

-

0.0

188.4

-

        Long Term Debt Issued

8.5

56.0

124.3

110.8

98.8

        Long Term Debt Reduction

-2.4

-50.8

-136.0

-246.8

-35.6

    Long Term Debt, Net

6.1

5.2

-11.7

-136.0

63.3

Issuance (Retirement) of Debt, Net

6.1

5.2

-11.7

-136.0

63.3

Cash from Financing Activities

5.3

3.5

-16.6

52.4

45.9

 

 

 

 

 

 

Foreign Exchange Effects

-

-

-

-

-0.2

Net Change in Cash

-1.9

10.6

-8.5

39.7

3.0

 

 

 

 

 

 

Net Cash - Beginning Balance

47.1

38.8

49.3

6.4

2.9

Net Cash - Ending Balance

45.2

49.5

40.9

46.2

5.9

Cash Interest Paid

5.5

6.2

12.3

19.0

17.3

Cash Taxes Paid

1.0

0.0

0.2

0.2

0.2

 

 

 

Interim Cash Flows

Standardized

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           

 

 

 

30-Jun-2011

31-Dec-2010

30-Jun-2010

31-Dec-2009

30-Jun-2009

Period Length

6 Months

12 Months

6 Months

12 Months

6 Months

UpdateType/Date

Updated Normal 
30-Jun-2011

Updated Normal 
31-Dec-2010

Updated Normal 
30-Jun-2010

Updated Normal 
31-Dec-2009

Updated Normal 
30-Jun-2009

Filed Currency

EUR

EUR

EUR

EUR

EUR

Exchange Rate (Period Average)

0.713558

0.755078

0.754409

0.719047

0.749639

 

 

 

 

 

 

Net Income/Starting Line

8.7

-18.3

-13.3

-70.9

-23.8

    Depreciation

13.0

25.6

13.3

23.4

10.9

Depreciation/Depletion

13.0

25.6

13.3

23.4

10.9

    Discontinued Operations

-

2.1

-

1.6

-

    Unusual Items

-2.0

-6.8

-2.7

-

-

    Other Non-Cash Items

0.0

0.3

2.1

19.0

-22.0

Non-Cash Items

-2.0

-4.4

-0.6

20.6

-22.0

    Accounts Receivable

-33.2

-21.0

-27.3

-

-

    Inventories

2.5

13.1

8.7

-

-

    Other Assets

0.1

1.7

-0.1

-

-

    Accounts Payable

54.9

-2.0

20.6

-

-

    Other Liabilities

-1.6

-3.3

9.4

-

-

    Other Assets & Liabilities, Net

-

-

-

110.8

110.1

    Other Operating Cash Flow

-3.1

-5.4

-1.9

-27.0

-3.3

Changes in Working Capital

19.6

-16.8

9.3

83.8

106.9

Cash from Operating Activities

39.4

-14.0

8.7

56.9

71.9

 

 

 

 

 

 

    Purchase of Fixed Assets

-3.2

-10.7

-8.9

-53.2

-35.4

    Purchase/Acquisition of Intangibles

0.0

-

-0.6

-

-

Capital Expenditures

-3.2

-10.7

-9.5

-53.2

-35.4

    Acquisition of Business

-

-

-

-1.7

-

    Sale of Fixed Assets

1.7

2.8

2.7

3.0

0.0

    Sale/Maturity of Investment

-

0.5

-

2.9

-

    Purchase of Investments

0.0

0.0

0.0

-0.8

-3.5

    Sale of Intangible Assets

5.5

2.1

0.1

-

-

    Other Investing Cash Flow

-

12.2

-

-

-

Other Investing Cash Flow Items, Total

7.2

17.5

2.8

3.4

-3.5

Cash from Investing Activities

4.1

6.8

-6.7

-49.8

-38.9

 

 

 

 

 

 

    Other Financing Cash Flow

0.0

-0.8

-0.8

-1.7

-1.3

Financing Cash Flow Items

0.0

-0.8

-0.8

-1.7

-1.3

    Total Debt Issued

31.8

8.5

14.2

56.0

67.4

    Total Debt Reduction

-41.8

-2.4

-11.8

-50.8

-78.0

Issuance (Retirement) of Debt, Net

-10.0

6.1

2.4

5.2

-10.6

Cash from Financing Activities

-10.0

5.3

1.6

3.5

-11.9

 

 

 

 

 

 

Net Change in Cash

33.5

-1.9

3.7

10.6

21.1

 

 

 

 

 

 

Net Cash - Beginning Balance

47.8

47.1

47.1

38.8

37.3

Net Cash - Ending Balance

81.3

45.2

50.8

49.5

58.4

Cash Interest Paid

3.3

5.5

2.6

6.2

3.8

 

 

Annual Income Statement

As Reported

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           

 

 

 

31-Dec-2010

31-Dec-2009

31-Dec-2008

31-Dec-2007

31-Dec-2006

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal 
31-Dec-2010

Updated Normal 
31-Dec-2009

Restated Normal 
31-Dec-2009

Reclassified Normal 
31-Dec-2008

Reclassified Normal 
31-Dec-2007

Filed Currency

EUR

EUR

EUR

EUR

EUR

Exchange Rate (Period Average)

0.755078

0.719047

0.683679

0.730637

0.796979

Auditor

Ernst & Young SA

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Sales of Products

806.9

792.5

1,220.8

1,156.0

904.7

    Service / Income

-

-

-

5.4

-

    Other Op. Income

12.3

50.7

30.0

29.4

57.1

Total Revenue

819.2

843.2

1,250.7

1,190.9

961.7

 

 

 

 

 

 

    Gains/Stocks

12.9

-8.7

-4.1

-

-10.0

    Consumption

397.0

409.2

696.8

604.8

460.5

    Personnel Expenses

117.5

147.7

155.7

186.4

136.1

    Depreciation/Amortization

25.6

23.4

57.3

56.0

50.8

    Other Op. Expenses

277.4

313.8

341.2

361.5

304.5

    Litigation

0.2

22.6

-

-

-

    Assets Impairment

-

-

290.0

-

-

Total Operating Expense

830.6

908.0

1,537.0

1,208.7

941.9

 

 

 

 

 

 

    Interest Income

0.0

0.0

0.8

32.5

1.5

    Other Financial Income

0.6

3.9

3.9

-

1.1

    Financial Expenses

-7.4

-6.3

-12.9

-21.5

-18.0

    Interest Expense

-0.4

-0.9

-1.8

-1.3

-1.4

    FOREX, Net

0.3

-1.3

-1.1

-1.9

-0.2

    Losses/Gains Equity Meth.

-

-

-

0.4

0.1

    Assets Write-Down

-

-

-

-36.0

0.0

Net Income Before Taxes

-18.3

-69.4

-297.4

-45.6

3.0

 

 

 

 

 

 

Provision for Income Taxes

0.1

1.5

0.0

0.3

-3.1

Net Income After Taxes

-18.4

-70.9

-297.4

-45.9

6.1

 

 

 

 

 

 

    Minority Interest

-0.3

0.5

-0.5

1.0

-0.5

Net Income Before Extra. Items

-18.6

-70.4

-297.9

-44.8

5.6

    Discontinued Operations

2.1

1.6

0.4

-

-

Net Income

-16.5

-68.8

-297.5

-44.8

5.6

 

 

 

 

 

 

Income Available to Com Excl ExtraOrd

-18.6

-70.4

-297.9

-44.8

5.6

 

 

 

 

 

 

Income Available to Com Incl ExtraOrd

-16.5

-68.8

-297.5

-44.8

5.6

 

 

 

 

 

 

Basic Weighted Average Shares

100.6

100.6

100.6

100.6

67.6

Basic EPS Excluding ExtraOrdinary Items

-0.19

-0.70

-2.96

-0.45

0.08

Basic EPS Including ExtraOrdinary Item

-0.16

-0.68

-2.96

-0.45

0.08

Dilution Adjustment

0.0

0.0

0.0

0.0

-

Diluted Net Income

-16.5

-68.8

-297.5

-44.8

5.6

Diluted Weighted Average Shares

100.6

100.6

100.6

100.6

67.6

Diluted EPS Excluding ExtraOrd Items

-0.19

-0.70

-2.96

-0.45

0.08

Diluted EPS Including ExtraOrd Items

-0.16

-0.68

-2.96

-0.45

0.08

DPS-Ordinary Shares

0.00

0.00

0.00

0.00

0.00

Gross Dividends - Common Stock

0.0

0.0

0.0

0.0

0.0

Normalized Income Before Taxes

-18.1

-46.7

-7.4

-45.6

3.0

 

 

 

 

 

 

Inc Tax Ex Impact of Sp Items

0.2

9.5

101.5

0.3

-3.1

Normalized Income After Taxes

-18.2

-56.2

-108.8

-45.9

6.1

 

 

 

 

 

 

Normalized Inc. Avail to Com.

-18.5

-55.7

-109.4

-44.8

5.6

 

 

 

 

 

 

Basic Normalized EPS

-0.18

-0.55

-1.09

-0.45

0.08

Diluted Normalized EPS

-0.18

-0.55

-1.09

-0.45

0.08

Interest Expense

0.4

0.9

1.8

1.3

1.4

Depreciation

25.0

22.6

57.6

56.0

50.8

Amortization of Intangibles

0.6

0.5

0.2

-

-

Research & Development Exp, Supplemental

0.4

0.4

0.6

-

-

Rental Expense, Supplemental

13.5

16.0

17.6

-

-

Advertising Expense, Supplemental

0.6

0.9

1.1

-

-

    Current Tax, Total

0.3

0.2

-0.8

0.2

1.4

Current Tax - Total

0.3

0.2

-0.8

0.2

1.4

    Deferred Tax, Total

-0.2

1.3

0.8

0.1

-4.5

Deferred Tax - Total

-0.2

1.3

0.8

0.1

-4.5

Income Tax - Total

0.1

1.5

0.0

0.3

-3.1

 

 

Interim Income Statement

As Reported

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           

 

 

 

30-Jun-2011

31-Dec-2010

30-Sep-2010

30-Jun-2010

31-Dec-2009

Period Length

6 Months

6 Months

9 Months

6 Months

6 Months

UpdateType/Date

Updated Normal 
30-Jun-2011

Updated Normal 
31-Dec-2010

Updated Special 
30-Sep-2010

Updated Normal 
30-Jun-2010

Updated Normal 
31-Dec-2009

Filed Currency

EUR

EUR

EUR

EUR

EUR

Exchange Rate (Period Average)

0.713558

0.75577

0.761121

0.754409

0.688522

 

 

 

 

 

 

    Net Turnover

511.5

415.1

595.0

391.7

389.8

    Other Op. Income

9.7

5.5

18.6

6.7

31.0

Total Revenue

521.3

420.7

613.6

398.4

420.8

 

 

 

 

 

 

    Stocks

-11.4

21.5

-

-8.6

-26.1

    Purchases

287.3

189.5

448.4

207.4

212.1

    Personnel Expenses

60.2

58.8

85.9

58.6

81.1

    Other Fixed Costs

-

-

69.8

-

-

    Other Op. Expenses

158.1

138.2

1.3

139.4

182.7

    Depreciation

13.0

12.3

19.7

13.3

13.1

    Loss/Assets

-

-

0.0

-

-

Total Operating Expense

507.2

420.4

625.1

410.2

462.9

 

 

 

 

 

 

    Financial Result - Ordinary

-

-

-4.1

-

-

    Other Financial Income

0.3

0.4

-

0.3

1.1

    Financial Expenses

-6.1

-4.5

-

-3.4

4.4

    Other Financial Expenses

-

-

-

-

-7.5

    Foreign Currency Adjustment

-0.1

-1.2

-

1.5

-1.1

    Equity Method

0.5

-

-

-

-

    Other Results

-

-

1.2

-

-

Net Income Before Taxes

8.7

-5.0

-14.3

-13.3

-45.2

 

 

 

 

 

 

Provision for Income Taxes

0.0

0.1

-0.1

-0.1

1.6

Net Income After Taxes

8.7

-5.1

-14.3

-13.3

-46.8

 

 

 

 

 

 

    Minority Interest

-0.1

-0.1

-0.3

-0.1

0.4

Net Income Before Extra. Items

8.6

-5.3

-14.5

-13.4

-46.5

    Discontinued Operations

0.0

1.4

-

0.7

0.8

Net Income

8.6

-3.9

-14.5

-12.7

-45.7

 

 

 

 

 

 

Income Available to Com Excl ExtraOrd

8.6

-5.3

-14.5

-13.4

-46.5

 

 

 

 

 

 

Income Available to Com Incl ExtraOrd

8.6

-3.9

-14.5

-12.7

-45.7

 

 

 

 

 

 

Basic Weighted Average Shares

100.6

100.6

100.6

100.6

100.6

Basic EPS Excluding ExtraOrdinary Items

0.09

-0.05

-0.14

-0.13

-0.46

Basic EPS Including ExtraOrdinary Item

0.09

-0.04

-0.14

-0.13

-0.45

Dilution Adjustment

-

0.0

0.0

0.0

0.0

Diluted Net Income

8.6

-3.9

-14.5

-12.7

-45.7

Diluted Weighted Average Shares

100.6

100.6

100.6

100.6

100.6

Diluted EPS Excluding ExtraOrd Items

0.09

-0.05

-0.14

-0.13

-0.46

Diluted EPS Including ExtraOrd Items

0.09

-0.04

-0.14

-0.13

-0.45

DPS-Ordinary Shares

0.00

0.00

0.00

0.00

0.00

Gross Dividends - Common Stock

0.0

0.0

0.0

0.0

0.0

Normalized Income Before Taxes

8.7

-5.0

-14.3

-13.3

-45.2

 

 

 

 

 

 

Inc Tax Ex Impact of Sp Items

0.0

0.1

-0.1

-0.1

1.6

Normalized Income After Taxes

8.7

-5.1

-14.3

-13.3

-46.8

 

 

 

 

 

 

Normalized Inc. Avail to Com.

8.6

-5.3

-14.5

-13.4

-46.5

 

 

 

 

 

 

Basic Normalized EPS

0.09

-0.05

-0.14

-0.13

-0.46

Diluted Normalized EPS

0.09

-0.05

-0.14

-0.13

-0.46

Depreciation

13.0

12.3

19.7

13.3

13.1

Advertising Expense, Supplemental

0.3

0.3

-

0.4

0.4

Rental Expense, Supplemental

6.6

6.0

-

7.5

8.1

 

 

Annual Balance Sheet

As Reported

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           

 

 

 

31-Dec-2010

31-Dec-2009

31-Dec-2008

31-Dec-2007

31-Dec-2006

UpdateType/Date

Updated Normal 
31-Dec-2010

Updated Normal 
31-Dec-2009

Updated Normal 
31-Dec-2008

Updated Normal 
31-Dec-2007

Updated Normal 
31-Dec-2006

Filed Currency

EUR

EUR

EUR

EUR

EUR

Exchange Rate

0.745406

0.696986

0.719399

0.683971

0.758351

Auditor

Ernst & Young SA

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

    Other Inventories

41.6

34.7

53.2

54.5

53.3

    Finished Goods

49.0

71.5

103.9

97.9

80.5

    Real Estate Development

-

-

-

0.0

1.8

    Accounts Rcvbl.

224.3

217.7

309.8

-

-

    Provisions

-14.0

-14.6

-10.5

-

-

    Other Receivable

-

-

-

42.7

29.7

    Accounts Receivable, Net

-

-

-

273.0

250.2

    Cash and Equivalents

23.4

21.0

3.0

49.3

6.2

    Asset Securization Fund

22.3

30.0

35.8

-

-

    Other Assets

22.9

26.3

13.3

42.1

29.2

    Assets Held for Sale

0.0

14.0

0.0

60.1

52.2

Total Current Assets

369.7

400.5

508.5

619.5

503.0

 

 

 

 

 

 

    Formation Exp.

-

-

-

0.8

6.3

    Concessions

-

-

-

6.8

5.9

    Software

-

-

-

8.9

6.3

    Right Emissions

-

-

-

5.7

9.1

    Other Intangibles

-

-

-

0.0

0.1

    Intangibles

24.5

23.9

24.3

-

-

    Amort. Intangi.

-11.8

-12.2

-11.8

-12.3

-11.9

    Provisions

-1.3

0.0

-

-5.7

0.0

    Land/Buildings

279.6

302.6

325.8

340.3

311.6

    Plant/Machine.

1,302.4

1,398.9

1,282.7

1,347.3

1,200.1

    Other Tangibles

30.6

35.2

34.9

36.6

34.4

    Work in Progress

21.4

31.5

50.2

23.3

26.4

    Depreciation

-978.4

-1,048.9

-1,001.9

-1,007.0

-873.5

    Provisions

-252.1

-273.6

-265.1

-31.0

-4.6

    Real Estate Investments

28.6

30.5

14.8

31.6

28.7

    LT Investments

16.9

18.6

7.9

10.5

74.8

    Invest./Equity

6.1

6.6

6.4

6.6

4.3

    Goodwill

0.1

0.1

0.0

0.1

0.1

    Deferred Tax

4.6

4.8

6.0

5.5

5.2

Total Assets

840.7

918.4

982.8

1,387.5

1,326.3

 

 

 

 

 

 

    Bonds

95.7

0.0

-

-

-

    Bank Loans

50.7

59.4

113.3

123.3

228.6

    Leasing Debts

1.4

1.5

1.9

1.4

1.8

    Accounts Payable

187.1

187.5

181.8

215.6

212.1

    Provisions

5.0

12.7

14.3

5.5

16.1

    Taxes

-

-

-

0.0

0.2

    Other Current Liabilities

36.5

3.2

57.8

81.4

86.6

    Suppliers of Fixed Assets

3.1

7.5

5.1

-

-

    Public Adminstration

11.8

12.5

2.8

-

-

    Unpaid Wages

11.8

6.6

6.5

-

-

    Liabilities Held for Sale

0.0

3.1

0.0

-

-

Total Current Liabilities

403.1

294.1

383.6

427.2

545.4

 

 

 

 

 

 

    Bonds

0.0

102.3

99.1

104.3

0.0

    Bank Loans

1.0

0.8

2.8

9.3

160.9

    Leasing Debts

1.4

2.8

1.8

3.0

1.7

Total Long Term Debt

2.4

106.0

103.7

116.5

162.6

 

 

 

 

 

 

    Provisions

57.1

90.9

70.1

100.5

82.8

    Minority Int.

0.6

0.4

1.8

1.3

2.6

    Deferred Tax

49.4

52.5

49.3

52.6

48.3

    Other LT Liabilities

71.0

80.1

18.6

13.5

12.5

Total Liabilities

583.5

624.1

627.1

711.7

854.2

 

 

 

 

 

 

    Share Capital

40.5

231.0

503.5

529.6

341.2

    Share Premium

-

0.0

151.7

159.6

90.9

    Legal Reserve

20.7

5.1

24.7

26.0

23.4

    Difference Reserve

0.1

0.1

0.1

0.1

0.1

    Other Reserves

233.8

151.4

-20.0

31.7

20.9

    Valuation Reserve

-1.1

-0.8

-0.8

-1.4

1.8

    Capital Increase Exp.

-20.1

-21.5

-20.8

-21.9

-12.1

    Profit & Loss

-16.7

-71.0

-282.7

-47.9

5.9

Total Equity

257.3

294.3

355.7

675.8

472.1

 

 

 

 

 

 

Total Liabilities & Shareholders' Equity

840.7

918.4

982.8

1,387.5

1,326.3

 

 

 

 

 

 

    S/O-Ordinary Shares

100.6

100.6

100.6

100.6

76.7

Total Common Shares Outstanding

100.6

100.6

100.6

100.6

76.7

T/S-Ordinary Shares

0.0

0.0

-

-

-

Accumulated Intangible Amortization

11.8

12.2

11.9

12.3

11.9

Full-Time Employees

1,610

1,713

1,898

2,100

2,162

LT Debt Maturing in 1 Year

50.7

59.4

113.3

124.7

230.3

LT Debt Maturing in 2 Years

0.0

0.9

2.7

7.6

36.0

LT Debt Maturing in 3 Years

1.0

0.4

1.0

2.8

30.9

LT Debt Maturing in 4 Years

0.0

0.5

0.4

1.4

28.1

LT Debt Maturing in 5 Years

0.0

0.1

0.2

0.2

27.0

LT Debt/ Remaining Maturities

-

0.0

0.3

0.2

40.6

Total Long Term Debt, Supplemental

51.6

61.2

117.9

137.0

393.0

Capital Leases Due Within 1 Y

1.4

1.5

1.9

1.4

-

Capital Leases Due Within 2 Y

0.8

1.0

0.8

1.0

-

Capital Leases Due Within 3 Y

0.5

0.6

0.7

0.7

-

Capital Leases Due Within 4 Y

0.1

0.3

0.3

0.7

-

Capital Leases/ Remaining Maturities

0.0

0.9

0.0

0.6

-

Total Capital Leases

2.8

4.3

3.7

4.4

-

Operating Leases within 1 Y

1.0

1.1

1.2

-

-

Operating Leases in 2 Y

0.0

-

1.2

-

-

Total Operating Leases

1.0

1.1

2.3

-

-

 

 

Interim Balance Sheet

As Reported

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           

 

 

 

30-Jun-2011

31-Mar-2011

31-Dec-2010

30-Jun-2010

31-Dec-2009

UpdateType/Date

Updated Normal 
30-Jun-2011

Updated Normal 
31-Mar-2011

Updated Normal 
31-Dec-2010

Updated Normal 
30-Jun-2010

Updated Normal 
31-Dec-2009

Filed Currency

EUR

EUR

EUR

EUR

EUR

Exchange Rate

0.689727

0.704672

0.745406

0.816393

0.696986

 

 

 

 

 

 

    Inventory

95.2

-

90.7

80.5

106.1

    Accounts Rcvbl.

261.2

-

210.4

195.2

203.1

    Cash and Equivalents

84.1

-

45.7

47.0

51.0

    Assets Held for Sale

-

-

0.0

15.2

14.0

    Current Assets

24.6

445.8

22.9

22.5

26.3

Total Current Assets

465.0

445.8

369.7

360.4

400.5

 

 

 

 

 

 

    Intangibles

11.0

-

11.4

12.3

11.8

    Tangibles

428.2

-

403.5

372.7

445.6

    Real Estate Investments

30.9

-

28.6

26.1

30.5

    Investment - Affiliates

8.3

-

6.1

5.6

6.6

    LT Financial Assets

18.3

-

16.9

15.3

18.6

    Deferred Tax

4.9

-

4.6

4.3

4.8

    Other LT Assets

-

497.9

-

-

-

Total Assets

966.5

943.7

840.7

796.7

918.4

 

 

 

 

 

 

    Bonds

103.4

-

95.7

-

-

    Bank Loans

45.8

-

52.1

55.7

60.9

    Accounts Payable

252.7

-

187.1

179.0

187.5

    Provisions

3.7

-

5.0

5.5

12.7

    Other ST Liabilities

68.1

474.5

63.2

49.5

29.9

    Assets Held fo Sale

-

-

0.0

5.2

3.1

    Issuance of obligations

-

-

-

87.3

-

Total Current Liabilities

473.6

474.5

403.1

382.2

294.1

 

 

 

 

 

 

    Bonds

0.0

-

0.0

-

-

    Bank Loans

1.3

-

2.4

2.1

106.0

Total Long Term Debt

1.3

-

2.4

2.1

106.0

 

 

 

 

 

 

    Provisions

60.0

-

57.1

58.6

90.9

    Minority Int.

0.8

0.7

0.6

0.4

0.4

    Deferred Tax

53.4

-

49.4

44.8

52.5

    Other LT Liabilities

89.4

191.1

71.0

70.9

80.1

Total Liabilities

678.4

666.3

583.5

559.2

624.1

 

 

 

 

 

 

    Share Capital

43.8

-

40.5

37.0

231.0

    Reserves

257.1

-

253.6

230.6

155.8

    Profit & Loss

8.9

-

-16.7

-11.7

-71.0

    Other

-21.7

-

-20.1

-18.3

-21.5

    Total Equity

-

277.4

-

-

-

Total Equity

288.1

277.4

257.3

237.5

294.3

 

 

 

 

 

 

Total Liabilities & Shareholders' Equity

966.5

943.7

840.7

796.7

918.4

 

 

 

 

 

 

    S/O-Ordinary Shares

100.6

100.6

100.6

100.6

100.6

Total Common Shares Outstanding

100.6

100.6

100.6

100.6

100.6

T/S-Ordinary Shares

0.0

-

0.0

0.0

0.0

Full-Time Employees

1,629

-

1,610

1,692

1,713

 

 

 

Annual Cash Flows

As Reported

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           

 

 

 

31-Dec-2010

31-Dec-2009

31-Dec-2008

31-Dec-2007

31-Dec-2006

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal 
31-Dec-2010

Updated Normal 
31-Dec-2009

Reclassified Normal 
31-Dec-2009

Reclassified Normal 
31-Dec-2008

Reclassified Normal 
31-Dec-2007

Filed Currency

EUR

EUR

EUR

EUR

EUR

Exchange Rate (Period Average)

0.755078

0.719047

0.683679

0.730637

0.796979

Auditor

Ernst & Young SA

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Ernst & Young LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified

Unqualified

Unqualified

 

 

 

 

 

 

Operating Profit / Loss

-18.3

-70.9

-297.4

-45.6

19.9

    Depreciation

25.6

23.4

58.1

56.0

-

    Value Correction on Impairments

-3.8

14.3

290.0

30.2

-

    Provisions

-1.2

37.4

5.4

36.6

15.4

    Subventions

-3.9

-4.7

-7.6

-1.9

-

    Impairment/Sale of Assets Result

-4.7

-39.3

-4.8

3.9

-

    Financial Income

-0.7

-3.9

-1.7

-32.5

-

    Financial Expense

7.8

7.2

2.9

22.8

-

    Exchange Difference

-0.3

1.3

-1.0

0.0

-

    Other Gains/Losses

2.4

6.7

19.0

15.8

-

    Negative Consolidation Difference

-

-

-

-

-32.9

    Works Fixed Assets

-

-

-

-

-2.3

    Amortization of Intangibles

-

-

-

-

50.8

    Inventories

13.1

35.4

-26.1

-3.3

-17.3

    Impairments due to Disc. Operations

-2.1

0.0

-

-

-

    Receivables

-21.0

81.8

-3.0

10.7

-11.1

    Other ST Assets

1.7

-13.4

26.2

0.7

-

    Payables

-2.0

0.8

-24.3

-18.4

-40.5

    Other ST Liabilities

-3.3

4.4

-7.0

-16.8

-

    Other LT Liabilities

0.0

1.7

-19.4

-5.5

-

    Interest Paid

-5.5

-6.2

-12.3

-19.0

-

    Interest Gained

1.1

1.2

3.0

2.3

-

    Tax Paid

-1.0

0.0

-0.2

-0.2

-0.2

    Other Payments

0.0

-21.9

0.0

-

-

    Discontinued Operations

2.1

1.6

0.4

-

-

    Miscalculous Adjustment

-

-0.1

-0.5

-13.7

-

Cash from Operating Activities

-14.0

56.9

0.0

22.0

-18.2

 

 

 

 

 

 

    Purchase of Tangibles

-10.7

-50.9

-56.6

-30.7

-29.0

    Purchase of Intangibles

0.0

-2.3

-1.1

-4.5

0.0

    Purchase of Investment

-

0.0

-0.1

0.0

-3.3

    Purchase of Business

0.0

-1.7

0.0

-

-

    Other Assets

-

-

0.0

-2.2

4.8

    Sale of Fixed Assets

2.8

0.1

0.5

0.0

-

    Purchase of Other Investment

0.0

-0.8

-0.9

-2.7

0.0

    Sale of Intangibles

2.1

2.9

4.8

0.0

0.4

    Sale of Other Investments

0.5

2.9

0.7

3.2

-

    Discontinued Operations

12.2

0.0

60.9

0.0

-

    Interest Received

-

-

-

-

2.6

    Miscalculous Adjustment

-

-

-

2.2

-

Cash from Investing Activities

6.8

-49.8

8.2

-34.7

-24.5

 

 

 

 

 

 

    Bank Loans Obtained

1.9

0.0

124.3

13.2

98.8

    Bank Loans Repaid

0.0

-50.8

-136.0

-246.8

-35.6

    Other Debt Issuance

6.5

56.0

0.0

-

-

    Other Debt Repaid

-2.4

-

-

-

-

    Increase of Capital

-

-

0.0

188.4

-

    Capital Premium

-

-

-

0.0

-

    Interest Received

-

-

-

-

0.0

    Interest Paid

-

-

-

-

-17.3

    Bonds Emission

-

-

-

97.6

-

    Dividends Paid

-0.8

-1.7

-5.0

-

-

    Adjustment

-

-

-

-

0.0

Cash from Financing Activities

5.3

3.5

-16.6

52.4

45.9

 

 

 

 

 

 

Foreign Exchange Effects

-

-

-

-

-0.2

Net Change in Cash

-1.9

10.6

-8.5

39.7

3.0

 

 

 

 

 

 

Net Cash-Beginning Balance

47.1

38.8

49.3

6.4

2.9

Net Cash-Ending Balance

45.2

49.5

40.9

46.2

5.9

    Cash Interest Paid

5.5

6.2

12.3

19.0

17.3

    Cash Taxes Paid

1.0

0.0

0.2

0.2

0.2

 

 

 

Interim Cash Flows

As Reported

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           

 

 

 

30-Jun-2011

31-Dec-2010

30-Jun-2010

31-Dec-2009

30-Jun-2009

Period Length

6 Months

12 Months

6 Months

12 Months

6 Months

UpdateType/Date

Updated Normal 
30-Jun-2011

Updated Normal 
31-Dec-2010

Updated Normal 
30-Jun-2010

Updated Normal 
31-Dec-2009

Updated Normal 
30-Jun-2009

Filed Currency

EUR

EUR

EUR

EUR

EUR

Exchange Rate (Period Average)

0.713558

0.755078

0.754409

0.719047

0.749639

 

 

 

 

 

 

Net Income

8.7

-18.3

-13.3

-70.9

-23.8

    Depreciation

13.0

25.6

13.3

23.4

10.9

    Other Non-Cash

-

-3.8

-

19.0

-22.0

    Provisions

0.8

-1.2

7.1

-

-

    Grants

-6.6

-3.9

-2.3

-

-

    Loss on Assets

-2.0

-6.8

-2.7

-

-

    Financial Income

-0.3

-0.7

-0.3

-

-

    Financial Expense

6.1

7.8

3.4

-

-

    Foreign Exchange Differences

0.1

-0.3

-1.5

-

-

    Other Financial

-0.1

2.4

-4.3

-

-

    Inventories

2.5

13.1

8.7

-

-

    Receivables

-33.2

-21.0

-27.3

-

-

    Other Assets

0.1

1.7

-0.1

-

-

    Payables

54.9

-2.0

20.6

-

-

    Other Liabilities

-1.6

-3.3

9.4

-

-

    Changes in Current Capital

-

-

-

110.8

110.1

    Interest Paid

-3.3

-5.5

-2.6

-6.2

-3.8

    Interest Collected

0.2

1.1

0.3

1.2

0.6

    Tax Paid

-

-1.0

-

-

-

    Other Operating CF

0.0

0.0

0.4

-22.0

-

    Discontinued Operations

-

2.1

-

1.6

-

    Adjustment

-

-

-

-0.1

-

Cash from Operating Activities

39.4

-14.0

8.7

56.9

71.9

 

 

 

 

 

 

    Capital Expenditures

-3.2

-10.7

-8.9

-53.2

-35.4

    Other Financial Assets Acquired

0.0

0.0

0.0

-0.8

-3.5

    Purchase of Intangibles

0.0

-

-0.6

-

-

    Sale of Intangibles

5.5

2.1

0.1

-

-

    Purchase of Business

-

-

-

-1.7

-

    Sale of Assets

1.7

2.8

2.7

3.0

0.0

    Sale of Investments

-

0.5

-

2.9

-

    Discontinued Operations

-

12.2

-

-

-

Cash from Investing Activities

4.1

6.8

-6.7

-49.8

-38.9

 

 

 

 

 

 

    Debt Issued

28.9

8.5

14.2

56.0

67.4

    Debt Paid

-41.8

-2.4

-11.8

-50.8

-78.0

    Dividends Paid

0.0

-0.8

-0.8

-1.7

-1.3

    Other Debt

2.9

-

-

-

-

Cash from Financing Activities

-10.0

5.3

1.6

3.5

-11.9

 

 

 

 

 

 

Net Change in Cash

33.5

-1.9

3.7

10.6

21.1

 

 

 

 

 

 

Net Cash- Begining Balance

47.8

47.1

47.1

38.8

37.3

Net Cash- Ending Balance

81.3

45.2

50.8

49.5

58.4

    Cash Interest Paid

3.3

5.5

2.6

6.2

3.8

 

 

 

Geographic Segments

 

Financials in: As Reported (mil)

Annual

 

 

 

External Revenue   USD (mil)

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

31-Dec-06

Spain

445.3

55.2 %

459.8

58 %

699.7

57.3 %

623.4

53.9 %

503.7

55.7 %

Other European Union

241.3

29.9 %

220.9

27.9 %

301.7

24.7 %

344.4

29.8 %

263.2

29.1 %

Other O.E.C.D.

39.5

4.9 %

37.5

4.7 %

92.5

7.6 %

74.2

6.4 %

57.4

6.3 %

Other Countries

80.8

10 %

74.3

9.4 %

126.8

10.4 %

114.1

9.9 %

80.3

8.9 %

Segment Total

806.9

100 %

792.5

100 %

1,220.8

100 %

1,156.0

100 %

904.7

100 %

Consolidated Total

806.9

100 %

792.5

100 %

1,220.8

100 %

1,156.0

100 %

904.7

100 %

Exchange Rate: EUR to USD

0.755078

 

0.719047

 

0.683679

 

0.730637

 

0.796979

 

Intersegment Revenue   USD (mil)

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

31-Dec-06

Spain

38.4

100 %

11.8

100 %

19.2

83.9 %

20.3

98.7 %

16.0

99.9 %

Other European Union

0.0

0 %

0.0

0 %

3.7

16.1 %

0.3

1.3 %

0.0

0.1 %

Other O.E.C.D.

0.0

0 %

0.0

0 %

0.0

0 %

0.0

0 %

-

-

Other Countries

0.0

0 %

0.0

0 %

0.0

0 %

0.0

0 %

-

-

Segment Total

38.4

100 %

11.8

100 %

22.9

100 %

20.5

100 %

16.0

100 %

Consolidated Total

38.4

100 %

11.8

100 %

22.9

100 %

20.5

100 %

16.0

100 %

Exchange Rate: EUR to USD

0.755078

 

0.719047

 

0.683679

 

0.730637

 

0.796979

 

 

Total Revenue   USD (mil)

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

31-Dec-06

Spain

483.7

57.2 %

471.5

58.6 %

718.9

57.8 %

643.6

54.7 %

519.8

56.5 %

Other European Union

241.3

28.5 %

220.9

27.5 %

305.4

24.6 %

344.6

29.3 %

263.2

28.6 %

Other O.E.C.D.

39.5

4.7 %

37.5

4.7 %

92.5

7.4 %

74.2

6.3 %

57.4

6.2 %

Other Countries

80.8

9.6 %

74.3

9.2 %

126.8

10.2 %

114.1

9.7 %

80.3

8.7 %

Segment Total

845.3

100 %

804.2

100 %

1,243.6

100 %

1,176.6

100 %

920.7

100 %

Consolidated Total

845.3

100 %

804.2

100 %

1,243.6

100 %

1,176.6

100 %

920.7

100 %

Exchange Rate: EUR to USD

0.755078

 

0.719047

 

0.683679

 

0.730637

 

0.796979

 

Total Assets   USD (mil)

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

31-Dec-06

Spain

840.7

100 %

918.4

100 %

952.8

96.9 %

1,355.9

97.7 %

1,256.5

98.6 %

Other European Union

0.0

0 %

0.0

0 %

30.0

3.1 %

31.6

2.3 %

17.5

1.4 %

Other O.E.C.D.

0.0

0 %

0.0

0 %

0.0

0 %

-

-

-

-

Other Countries

0.0

0 %

0.0

0 %

0.0

0 %

-

-

-

-

Segment Total

840.7

100 %

918.4

100 %

982.8

100 %

1,387.5

100 %

1,274.1

100 %

Consolidated Total

840.7

100 %

918.4

100 %

982.8

100 %

1,387.5

100 %

1,274.1

100 %

Exchange Rate: EUR to USD

0.745406

 

0.696986

 

0.719399

 

0.683971

 

0.758351

 

 

Purchase of Fixed Assets   USD (mil)

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

Spain

14.6

100 %

53.9

100 %

46.6

98.3 %

34.5

97.9 %

Other European Union

0.0

0 %

0.0

0 %

0.8

1.7 %

0.7

2.1 %

Other O.E.C.D.

0.0

0 %

0.0

0 %

0.0

0 %

-

-

Other Countries

0.0

0 %

0.0

0 %

0.0

0 %

-

-

Segment Total

14.6

100 %

53.9

100 %

47.4

100 %

35.2

100 %

Consolidated Total

14.6

100 %

53.9

100 %

47.4

100 %

35.2

100 %

Exchange Rate: EUR to USD

0.755078

 

0.719047

 

0.683679

 

0.730637

 

 

 

Geographic Segments

Financials in: As Reported (mil)

Interim  

            

 

External Revenue   USD (mil)

 

30-Jun-11

31-Dec-10

30-Jun-10

31-Dec-09

30-Jun-09

Spain

288.1

55.3 %

256.4

57.4 %

227.3

57.1 %

229.9

60.5 %

241.1

57.1 %

European Union

152.1

29.2 %

127.6

28.5 %

113.7

28.5 %

100.7

26.5 %

119.4

28.3 %

Other O.E.C.D.

29.8

5.7 %

18.9

4.2 %

20.6

5.2 %

21.2

5.6 %

16.4

3.9 %

Other Countries

51.2

9.8 %

44.0

9.9 %

36.8

9.2 %

28.2

7.4 %

45.4

10.7 %

Segment Total

521.3

100 %

446.8

100 %

398.4

100 %

380.1

100 %

422.3

100 %

Consolidated Total

521.3

100 %

446.8

100 %

398.4

100 %

380.1

100 %

422.3

100 %

Exchange Rate: EUR to USD

0.713558

 

0.755770

 

0.754409

 

0.688522

 

0.749639

 

Total Revenue   USD (mil)

 

30-Jun-11

31-Dec-10

30-Jun-10

31-Dec-09

30-Jun-09

Spain

288.1

55.3 %

256.4

57.4 %

227.3

57.1 %

229.9

60.5 %

241.1

57.1 %

European Union

152.1

29.2 %

127.6

28.5 %

113.7

28.5 %

100.7

26.5 %

119.4

28.3 %

Other O.E.C.D.

29.8

5.7 %

18.9

4.2 %

20.6

5.2 %

21.2

5.6 %

16.4

3.9 %

Other Countries

51.2

9.8 %

44.0

9.9 %

36.8

9.2 %

28.2

7.4 %

45.4

10.7 %

Segment Total

521.3

100 %

446.8

100 %

398.4

100 %

380.1

100 %

422.3

100 %

Consolidated Total

521.3

100 %

446.8

100 %

398.4

100 %

380.1

100 %

422.3

100 %

Exchange Rate: EUR to USD

0.713558

 

0.755770

 

0.754409

 

0.688522

 

0.749639

 

 

Total Assets   USD (mil)

 

30-Jun-11

31-Dec-10

30-Jun-10

31-Dec-09

30-Jun-09

Spain

966.5

100 %

840.7

100 %

772.7

97 %

918.4

100 %

919.7

97.3 %

European Union

0.0

0 %

0.0

0 %

23.9

3 %

0.0

0 %

25.5

2.7 %

Other O.E.C.D.

0.0

0 %

0.0

0 %

0.0

0 %

0.0

0 %

0.0

0 %

Other Countries

0.0

0 %

0.0

0 %

0.0

0 %

0.0

0 %

0.0

0 %

Segment Total

966.5

100 %

840.7

100 %

796.7

100 %

918.4

100 %

945.2

100 %

Consolidated Total

966.5

100 %

840.7

100 %

796.7

100 %

918.4

100 %

945.2

100 %

Exchange Rate: EUR to USD

0.689727

 

0.745406

 

0.816393

 

0.696986

 

0.712936

 

Purchase of Fixed Assets   USD (mil)

 

30-Jun-11

31-Dec-10

30-Jun-10

31-Dec-09

30-Jun-09

Spain

4.7

100 %

9.7

100 %

4.8

100 %

21.6

102.8 %

31.8

98.3 %

European Union

0.0

0 %

0.0

0 %

0.0

0 %

-0.6

-2.8 %

0.5

1.7 %

Other O.E.C.D.

0.0

0 %

0.0

0 %

0.0

0 %

0.0

0 %

0.0

0 %

Other Countries

0.0

0 %

0.0

0 %

0.0

0 %

0.0

0 %

0.0

0 %

Segment Total

4.7

100 %

9.7

100 %

4.8

100 %

21.0

100 %

32.4

100 %

Consolidated Total

4.7

100 %

9.7

100 %

4.8

100 %

21.0

100 %

32.4

100 %

Exchange Rate: EUR to USD

0.713558

 

0.755770

 

0.754409

 

0.688522

 

0.749639

 

 

 

Business Segments

 

Financials in: As Reported (mil)

Annual

 

 

 

External Revenue   USD (mil)

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

31-Dec-06

Business Related to Chlorine

540.5

67 %

558.1

70.4 %

841.6

68.9 %

748.3

64.7 %

648.5

71.7 %

Intermediate Chemical

220.5

27.3 %

185.1

23.4 %

319.6

26.2 %

304.4

26.3 %

164.8

18.2 %

Pharmaceuticals

45.8

5.7 %

49.2

6.2 %

59.6

4.9 %

60.7

5.3 %

57.4

6.3 %

Emulsions

0.0

0 %

0.0

0 %

0.0

0 %

42.6

3.7 %

34.1

3.8 %

Basic Chemicals

-

-

-

-

-

-

-

-

353.9

39.1 %

Plastics

-

-

-

-

-

-

-

-

216.8

24 %

Agrochemicals and Animal Food

-

-

-

-

-

-

-

-

49.0

5.4 %

Water Treatment

-

-

-

-

-

-

-

-

28.8

3.2 %

Segment Total

806.9

100 %

792.5

100 %

1,220.8

100 %

1,156.0

100 %

904.7

100 %

Consolidated Total

806.9

100 %

792.5

100 %

1,220.8

100 %

1,156.0

100 %

904.7

100 %

Exchange Rate: EUR to USD

0.755078

 

0.719047

 

0.683679

 

0.730637

 

0.796979

 

Intersegment Revenue   USD (mil)

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

31-Dec-06

Business Related to Chlorine

0.0

0 %

11.2

95 %

19.7

86 %

16.7

81.5 %

12.6

78.7 %

Intermediate Chemical

0.0

0 %

0.6

5 %

3.2

14 %

3.6

17.3 %

3.2

20 %

Pharmaceuticals

0.0

0 %

0.0

0 %

0.0

0 %

0.0

0 %

0.0

0 %

Emulsions

0.0

0 %

0.0

0 %

0.0

0 %

0.2

1.1 %

0.2

1.3 %

Segment Total

0.0

0 %

11.8

100 %

22.9

100 %

20.5

100 %

16.0

100 %

Consolidated Total

0.0

0 %

11.8

100 %

22.9

100 %

20.5

100 %

16.0

100 %

Exchange Rate: EUR to USD

0.755078

 

0.719047

 

0.683679

 

0.730637

 

0.796979

 

 

Total Revenue   USD (mil)

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

31-Dec-06

Business Related to Chlorine

540.5

67 %

569.3

70.8 %

861.2

69.3 %

765.0

65 %

661.1

71.8 %

Intermediate Chemical

220.5

27.3 %

185.7

23.1 %

322.8

26 %

308.0

26.2 %

168.0

18.2 %

Pharmaceuticals

45.8

5.7 %

49.2

6.1 %

59.6

4.8 %

60.7

5.2 %

57.4

6.2 %

Emulsions

0.0

0 %

0.0

0 %

0.0

0 %

42.8

3.6 %

34.3

3.7 %

Basic Chemicals

-

-

-

-

-

-

-

-

353.9

38.4 %

Plastics

-

-

-

-

-

-

-

-

216.8

23.5 %

Agrochemicals and Animal Food

-

-

-

-

-

-

-

-

49.0

5.3 %

Water Treatment

-

-

-

-

-

-

-

-

28.8

3.1 %

Segment Total

806.9

100 %

804.2

100 %

1,243.6

100 %

1,176.6

100 %

920.7

100 %

Consolidated Total

806.9

100 %

804.2

100 %

1,243.6

100 %

1,176.6

100 %

920.7

100 %

Exchange Rate: EUR to USD

0.755078

 

0.719047

 

0.683679

 

0.730637

 

0.796979

 

Gross Profit   USD (mil)

 

31-Dec-10

31-Dec-09

31-Dec-08

Business Related to Chlorine

-6.1

-43.2 %

-54.3

131.1 %

44.5

72.9 %

Intermediate Chemical

21.5

151.9 %

14.0

-33.9 %

16.6

27.2 %

Pharmaceuticals

-1.2

-8.7 %

-1.2

2.8 %

0.0

0 %

Emulsions

0.0

0 %

0.0

0 %

0.0

0 %

Segment Total

14.1

100 %

-41.4

100 %

61.1

100 %

Consolidated Total

14.1

100 %

-41.4

100 %

61.1

100 %

Exchange Rate: EUR to USD

0.755078

 

0.719047

 

0.683679

 

 

Gross Margin (%)  

 

31-Dec-10

31-Dec-09

31-Dec-08

Business Related to Chlorine

-1.1

-

-9.5

-

5.2

-

Intermediate Chemical

9.7

-

7.6

-

5.1

-

Pharmaceuticals

-2.7

-

-2.3

-

0.0

-

Segment Total

1.8

-

-5.1

-

4.9

-

Consolidated Total

1.8

-

-5.1

-

4.9

-

Depreciation   USD (mil)

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

31-Dec-06

Business Related to Chlorine

18.9

73.8 %

14.7

62.9 %

41.3

72.1 %

38.0

67.8 %

36.9

72.6 %

Intermediate Chemical

6.6

26 %

8.6

36.8 %

11.7

20.4 %

13.2

23.6 %

9.3

18.4 %

Pharmaceuticals

0.1

0.2 %

0.1

0.3 %

4.3

7.5 %

4.1

7.4 %

3.9

7.7 %

Emulsions

0.0

0 %

0.0

0 %

0.0

0 %

0.7

1.2 %

0.7

1.3 %

Segment Total

25.6

100 %

23.4

100 %

57.3

100 %

56.0

100 %

50.8

100 %

Consolidated Total

25.6

100 %

23.4

100 %

57.3

100 %

56.0

100 %

50.8

100 %

Exchange Rate: EUR to USD

0.755078

 

0.719047

 

0.683679

 

0.730637

 

0.796979

 

 

Operating Income/Loss   USD (mil)

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

31-Dec-06

Business Related to Chlorine

-25.0

218.5 %

-69.0

106.5 %

3.2

84.2 %

-13.5

75.7 %

-9.6

-48.3 %

Intermediate Chemical

14.8

-129.8 %

5.4

-8.4 %

4.9

129.7 %

6.6

-36.8 %

30.4

153.1 %

Pharmaceuticals

-1.3

11.2 %

-1.2

1.9 %

-4.3

-113.9 %

-13.0

72.8 %

-2.7

-13.8 %

Emulsions

0.0

0 %

0.0

0 %

0.0

0 %

2.1

-11.7 %

1.8

9 %

Segment Total

-11.4

100 %

-64.8

100 %

3.8

100 %

-17.8

100 %

19.9

100 %

Consolidated Total

-11.4

100 %

-64.8

100 %

3.8

100 %

-17.8

100 %

19.9

100 %

Exchange Rate: EUR to USD

0.755078

 

0.719047

 

0.683679

 

0.730637

 

0.796979

 

Operating Margin (%)  

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

31-Dec-06

Business Related to Chlorine

-4.6

-

-12.1

-

0.4

-

-1.8

-

-1.5

-

Intermediate Chemical

6.7

-

2.9

-

1.5

-

2.1

-

18.1

-

Pharmaceuticals

-2.8

-

-2.5

-

-7.2

-

-21.4

-

-4.8

-

Emulsions

-

-

-

-

4.0

-

4.9

-

5.2

-

Segment Total

-1.4

-

-8.1

-

0.3

-

-1.5

-

2.2

-

Consolidated Total

-1.4

-

-8.1

-

0.3

-

-1.5

-

2.2

-

 

Interest Income (Expense) - Net Non-Operating   USD (mil)

 

31-Dec-10

31-Dec-09

31-Dec-08

Business Related to Chlorine

-4.8

66.8 %

-2.3

69.5 %

-6.6

66.1 %

Intermediate Chemical

-1.9

26.8 %

-0.8

24 %

-2.6

26.1 %

Pharmaceuticals

-0.5

6.5 %

-0.2

6.4 %

-0.8

7.9 %

Emulsions

-

-

-

-

0.0

0 %

Segment Total

-7.2

100 %

-3.2

100 %

-10.0

100 %

Consolidated Total

-7.2

100 %

-3.2

100 %

-10.0

100 %

Exchange Rate: EUR to USD

0.755078

 

0.719047

 

0.683679

 

Income Before Tax   USD (mil)

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

31-Dec-06

Business Related to Chlorine

-29.6

161.7 %

-72.4

104.3 %

-242.4

81.9 %

-34.8

76.3 %

-20.2

-668.9 %

Intermediate Chemical

13.0

-71.1 %

4.5

-6.5 %

-1.6

0.5 %

4.7

-10.3 %

27.0

891.3 %

Pharmaceuticals

-1.7

9.4 %

-1.5

2.2 %

-53.4

18 %

-17.1

37.5 %

-5.0

-164.7 %

Emulsions

-

-

0.0

0 %

0.0

0 %

1.6

-3.4 %

1.3

42.3 %

Adjustment

-

-

-

-

1.5

-0.5 %

-

-

-

-

Segment Total

-18.3

100 %

-69.4

100 %

-295.9

100 %

-45.6

100 %

3.0

100 %

Consolidated Total

-18.3

100 %

-69.4

100 %

-295.9

100 %

-45.6

100 %

3.0

100 %

Exchange Rate: EUR to USD

0.755078

 

0.719047

 

0.683679

 

0.730637

 

0.796979

 

 

Pre-Tax Margin (%)  

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

31-Dec-06

Business Related to Chlorine

-5.5

-

-12.7

-

-28.1

-

-4.5

-

-3.1

-

Intermediate Chemical

5.9

-

2.4

-

-0.5

-

1.5

-

16.0

-

Pharmaceuticals

-3.8

-

-3.1

-

-89.5

-

-28.1

-

-8.7

-

Emulsions

-

-

-

-

3.0

-

3.6

-

3.7

-

Segment Total

-2.3

-

-8.6

-

-23.8

-

-3.9

-

0.3

-

Consolidated Total

-2.3

-

-8.6

-

-23.8

-

-3.9

-

0.3

-

Total Income Tax   USD (mil)

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

31-Dec-06

Business Related to Chlorine

0.1

23.1 %

-1.0

93.5 %

-0.4

-82.4 %

0.7

94.4 %

1.6

63.9 %

Intermediate Chemical

0.0

0 %

-0.3

29.9 %

-0.1

-23.5 %

0.0

-3.7 %

0.6

24.9 %

Pharmaceuticals

0.3

76.9 %

0.3

-23.4 %

1.0

200 %

0.1

13 %

0.3

11.2 %

Emulsions

0.0

0 %

0.0

0 %

1.0

200 %

0.0

-3.7 %

-

-

Adjustment

-

-

-

-

0.0

5.9 %

-

-

-

-

Segment Total

0.3

100 %

-1.1

100 %

0.5

100 %

0.7

100 %

2.6

100 %

Consolidated Total

0.3

100 %

-1.1

100 %

0.5

100 %

0.7

100 %

2.6

100 %

Exchange Rate: EUR to USD

0.755078

 

0.719047

 

0.683679

 

0.730637

 

0.796979

 

 

Income After Tax   USD (mil)

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

31-Dec-06

Business Related to Chlorine

-29.7

179.7 %

-73.4

106.6 %

-242.0

81.4 %

-34.1

75.9 %

-18.6

-332.1 %

Intermediate Chemical

13.0

-78.8 %

4.2

-6.1 %

-1.5

0.5 %

4.7

-10.4 %

27.6

493 %

Pharmaceuticals

-2.0

12 %

-1.3

1.8 %

-54.4

18.3 %

-17.0

37.9 %

-4.7

-83.9 %

Emulsions

2.1

-12.9 %

1.6

-2.4 %

0.4

-0.1 %

1.5

-3.4 %

1.3

22.9 %

Segment Total

-16.5

100 %

-68.8

100 %

-297.5

100 %

-44.8

100 %

5.6

100 %

Consolidated Total

-16.5

100 %

-68.8

100 %

-297.5

100 %

-44.8

100 %

5.6

100 %

Exchange Rate: EUR to USD

0.755078

 

0.719047

 

0.683679

 

0.730637

 

0.796979

 

Net Profit Margin (%)  

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

31-Dec-06

Business Related to Chlorine

-5.5

-

-12.9

-

-28.1

-

-4.5

-

-2.8

-

Intermediate Chemical

5.9

-

2.3

-

-0.5

-

1.5

-

16.4

-

Pharmaceuticals

-4.3

-

-2.6

-

-91.2

-

-28.0

-

-8.2

-

Emulsions

-

-

-

-

0.9

-

3.5

-

3.7

-

Segment Total

-2.0

-

-8.6

-

-23.9

-

-3.8

-

0.6

-

Consolidated Total

-2.0

-

-8.6

-

-23.9

-

-3.8

-

0.6

-

 

Total Assets   USD (mil)

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

31-Dec-06

Business Related to Chlorine

508.2

60.4 %

571.5

62.2 %

596.9

60.7 %

844.6

60.9 %

851.0

64.2 %

Intermediate Chemical

238.1

28.3 %

239.2

26 %

273.4

27.8 %

409.0

29.5 %

361.4

27.2 %

Pharmaceuticals

94.4

11.2 %

93.7

10.2 %

97.7

9.9 %

118.6

8.5 %

101.9

7.7 %

Emulsions

0.0

0 %

14.0

1.5 %

14.9

1.5 %

15.3

1.1 %

12.0

0.9 %

Segment Total

840.7

100 %

918.4

100 %

982.8

100 %

1,387.5

100 %

1,326.3

100 %

Consolidated Total

840.7

100 %

918.4

100 %

982.8

100 %

1,387.5

100 %

1,326.3

100 %

Exchange Rate: EUR to USD

0.745406

 

0.696986

 

0.719399

 

0.683971

 

0.758351

 

Operating Return on Assets (%)  

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

31-Dec-06

Business Related to Chlorine

-5.0

-

-12.5

-

0.5

-

-1.7

-

-1.2

-

Intermediate Chemical

6.3

-

2.3

-

1.7

-

1.7

-

8.8

-

Pharmaceuticals

-1.4

-

-1.3

-

-4.2

-

-11.7

-

-2.8

-

Emulsions

-

-

0.0

-

0.0

-

14.6

-

15.6

-

Segment Total

-1.4

-

-7.3

-

0.4

-

-1.4

-

1.6

-

Consolidated Total

-1.4

-

-7.3

-

0.4

-

-1.4

-

1.6

-

 

Total Liabilities   USD (mil)

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

31-Dec-06

Business Related to Chlorine

459.3

78.8 %

440.9

70.7 %

462.6

74 %

521.1

73.4 %

551.7

64.8 %

Intermediate Chemical

86.0

14.8 %

86.1

13.8 %

110.4

17.7 %

132.0

18.6 %

224.1

26.3 %

Pharmaceuticals

37.5

6.4 %

93.7

15 %

44.8

7.2 %

51.5

7.2 %

69.8

8.2 %

Emulsions

0.0

0 %

3.1

0.5 %

7.5

1.2 %

5.8

0.8 %

6.0

0.7 %

Segment Total

582.8

100 %

623.7

100 %

625.3

100 %

710.4

100 %

851.6

100 %

Consolidated Total

582.8

100 %

623.7

100 %

625.3

100 %

710.4

100 %

851.6

100 %

Exchange Rate: EUR to USD

0.745406

 

0.696986

 

0.719399

 

0.683971

 

0.758351

 

Purchase of Fixed Assets   USD (mil)

 

31-Dec-10

31-Dec-09

31-Dec-08

31-Dec-07

Business Related to Chlorine

8.0

55 %

48.5

86.2 %

49.3

83.4 %

15.3

45.4 %

Intermediate Chemical

0.3

2.1 %

0.7

1.3 %

4.6

7.7 %

15.4

45.6 %

Pharmaceuticals

6.3

42.9 %

7.1

12.5 %

4.1

6.9 %

2.4

7.1 %

Emulsions

0.0

0 %

0.0

0 %

1.2

2 %

0.7

1.9 %

Segment Total

14.6

100 %

56.3

100 %

59.1

100 %

33.8

100 %

Consolidated Total

14.6

100 %

56.3

100 %

59.1

100 %

33.8

100 %

Exchange Rate: EUR to USD

0.755078

 

0.719047

 

0.683679

 

0.730637

 

 

 

Business Segments

 

Financials in: As Reported (mil)

 

Interim

 

 

External Revenue   USD (mil)

 

30-Jun-11

31-Dec-10

30-Jun-10

31-Dec-09

30-Jun-09

Business Related to Chlorine

352.3

67.6 %

275.4

67.4 %

265.1

66.5 %

255.4

67.2 %

311.5

73.8 %

Intermediate Chemicals

140.9

27 %

110.5

27.1 %

110.0

27.6 %

100.0

26.3 %

86.3

20.4 %

Pharmaceuticals

28.0

5.4 %

22.5

5.5 %

23.3

5.8 %

24.7

6.5 %

24.5

5.8 %

Emulsions

-

-

0.0

0 %

0.0

0 %

0.0

0 %

0.0

0 %

Segment Total

521.3

100 %

408.4

100 %

398.4

100 %

380.1

100 %

422.3

100 %

Consolidated Total

521.3

100 %

408.4

100 %

398.4

100 %

380.1

100 %

422.3

100 %

Exchange Rate: EUR to USD

0.713558

 

0.755770

 

0.754409

 

0.688522

 

0.749639

 

Total Revenue   USD (mil)

 

30-Jun-11

31-Dec-10

30-Jun-10

31-Dec-09

30-Jun-09

Business Related to Chlorine

352.3

67.6 %

275.4

67.4 %

265.1

66.5 %

255.4

67.2 %

311.5

73.8 %

Intermediate Chemicals

140.9

27 %

110.5

27.1 %

110.0

27.6 %

100.0

26.3 %

86.3

20.4 %

Pharmaceuticals

28.0

5.4 %

22.5

5.5 %

23.3

5.8 %

24.7

6.5 %

24.5

5.8 %

Emulsions

-

-

0.0

0 %

0.0

0 %

0.0

0 %

0.0

0 %

Segment Total

521.3

100 %

408.4

100 %

398.4

100 %

380.1

100 %

422.3

100 %

Consolidated Total

521.3

100 %

408.4

100 %

398.4

100 %

380.1

100 %

422.3

100 %

Exchange Rate: EUR to USD

0.713558

 

0.755770

 

0.754409

 

0.688522

 

0.749639

 

 

Depreciation   USD (mil)

 

30-Jun-11

31-Dec-10

30-Jun-10

31-Dec-09

30-Jun-09

Business Related to Chlorine

10.3

79.1 %

9.6

78.2 %

9.3

69.8 %

8.1

62.2 %

6.7

63.7 %

Intermediate Chemicals

2.7

20.7 %

3.0

24.7 %

3.6

27.1 %

4.9

37.6 %

3.8

35.9 %

Pharmaceuticals

0.0

0.2 %

-0.4

-2.9 %

0.4

3.1 %

0.0

0.2 %

0.0

0.4 %

Emulsions

-

-

0.0

0 %

0.0

0 %

0.0

0 %

0.0

0 %

Segment Total

13.0

100 %

12.3

100 %

13.3

100 %

13.1

100 %

10.5

100 %

Consolidated Total

13.0

100 %

12.3

100 %

13.3

100 %

13.1

100 %

10.5

100 %

Exchange Rate: EUR to USD

0.713558

 

0.755770

 

0.754409

 

0.688522

 

0.749639

 

Income Before Tax   USD (mil)

 

30-Jun-11

31-Dec-10

30-Jun-10

31-Dec-09

30-Jun-09

Business Related to Chlorine

2.3

26 %

-8.4

167.9 %

-21.2

159.4 %

-47.9

106 %

-25.4

101.4 %

Intermediate Chemicals

8.3

95.2 %

5.2

-103.7 %

7.8

-58.9 %

2.7

-6 %

1.8

-7.4 %

Pharmaceuticals

-1.8

-21.2 %

-1.8

35.8 %

0.1

-0.5 %

0.0

-0.1 %

-1.5

5.9 %

Emulsions

-

-

0.0

0 %

0.0

0 %

0.0

0 %

0.0

0 %

Segment Total

8.7

100 %

-5.0

100 %

-13.3

100 %

-45.2

100 %

-25.0

100 %

Consolidated Total

8.7

100 %

-5.0

100 %

-13.3

100 %

-45.2

100 %

-25.0

100 %

Exchange Rate: EUR to USD

0.713558

 

0.755770

 

0.754409

 

0.688522

 

0.749639

 

 

Pre-Tax Margin (%)  

 

30-Jun-11

31-Dec-10

30-Jun-10

31-Dec-09

30-Jun-09

Business Related to Chlorine

0.6

-

-3.0

-

-8.0

-

-18.8

-

-8.1

-

Intermediate Chemicals

5.9

-

4.7

-

7.1

-

2.7

-

2.1

-

Pharmaceuticals

-6.6

-

-7.9

-

0.3

-

0.1

-

-6.0

-

Segment Total

1.7

-

-1.2

-

-3.3

-

-11.9

-

-5.9

-

Consolidated Total

1.7

-

-1.2

-

-3.3

-

-11.9

-

-5.9

-

Income After Tax   USD (mil)

 

30-Jun-11

31-Dec-10

30-Jun-10

31-Dec-09

30-Jun-09

Business Related to Chlorine

2.3

26.2 %

-8.5

219.5 %

-21.2

167.5 %

-49.0

107.3 %

-25.4

105.4 %

Intermediate Chemicals

8.3

96.4 %

5.2

-133.6 %

7.9

-62.1 %

2.4

-5.2 %

1.9

-7.7 %

Pharmaceuticals

-1.9

-22.6 %

-1.9

50.3 %

0.0

0.3 %

0.2

-0.4 %

-1.4

5.7 %

Emulsions

-

-

1.4

-36.3 %

0.7

-5.8 %

0.8

-1.7 %

0.8

-3.4 %

Segment Total

8.6

100 %

-3.9

100 %

-12.7

100 %

-45.7

100 %

-24.1

100 %

Consolidated Total

8.6

100 %

-3.9

100 %

-12.7

100 %

-45.7

100 %

-24.1

100 %

Exchange Rate: EUR to USD

0.713558

 

0.755770

 

0.754409

 

0.688522

 

0.749639

 

 

Net Profit Margin (%)  

 

30-Jun-11

31-Dec-10

30-Jun-10

31-Dec-09

30-Jun-09

Business Related to Chlorine

0.6

-

-3.1

-

-8.0

-

-19.2

-

-8.1

-

Intermediate Chemicals

5.9

-

4.7

-

7.1

-

2.4

-

2.1

-

Pharmaceuticals

-7.0

-

-8.6

-

-0.2

-

0.7

-

-5.6

-

Segment Total

1.7

-

-0.9

-

-3.2

-

-12.0

-

-5.7

-

Consolidated Total

1.7

-

-0.9

-

-3.2

-

-12.0

-

-5.7

-

Total Assets   USD (mil)

 

30-Jun-11

31-Dec-10

30-Jun-10

31-Dec-09

30-Jun-09

Business Related to Chlorine

608.3

62.9 %

508.2

60.4 %

478.1

60 %

571.5

62.2 %

590.7

62.4 %

Intermediate Chemicals

265.5

27.5 %

238.1

28.3 %

209.7

26.3 %

239.2

26 %

234.3

24.7 %

Pharmaceuticals

92.7

9.6 %

94.4

11.2 %

93.8

11.8 %

93.7

10.2 %

104.9

11.1 %

Emulsions

-

-

0.0

0 %

15.2

1.9 %

14.0

1.5 %

17.3

1.8 %

Segment Total

966.5

100 %

840.7

100 %

796.7

100 %

918.4

100 %

947.2

100 %

Consolidated Total

966.5

100 %

840.7

100 %

796.7

100 %

918.4

100 %

947.2

100 %

Exchange Rate: EUR to USD

0.689727

 

0.745406

 

0.816393

 

0.696986

 

0.712936

 

 

Total Liabilities   USD (mil)

 

30-Jun-11

31-Dec-10

30-Jun-10

31-Dec-09

30-Jun-09

Business Related to Chlorine

517.7

76.4 %

459.3

78.8 %

417.5

74.7 %

440.9

70.7 %

437.1

71.4 %

Intermediate Chemicals

120.6

17.8 %

86.0

14.8 %

91.3

16.3 %

86.1

13.8 %

117.8

19.2 %

Pharmaceuticals

39.3

5.8 %

37.5

6.4 %

44.7

8 %

93.7

15 %

51.4

8.4 %

Emulsions

-

-

0.0

0 %

5.2

0.9 %

3.1

0.5 %

6.0

1 %

Segment Total

677.6

100 %

582.8

100 %

558.7

100 %

623.7

100 %

612.3

100 %

Consolidated Total

677.6

100 %

582.8

100 %

558.7

100 %

623.7

100 %

612.3

100 %

Exchange Rate: EUR to USD

0.689727

 

0.745406

 

0.816393

 

0.696986

 

0.712936

 

 


 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.48.92

UK Pound

1

Rs.77.31

Euro

1

Rs.64.12

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.